GrpL	B-protein
,	O
a	O
Grb2	B-protein
-related	O
adaptor	B-protein
protein	I-protein
,	O
interacts	O
with	O
SLP-76	B-protein
to	O
regulate	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cell	I-protein
activation	O
.	O

Propagation	O
of	O
signals	O
from	O
the	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
involves	O
a	O
number	O
of	O
adaptor	O
molecules	O
.	O

SH2	B-protein
domain-containing	I-protein
protein	I-protein
76	I-protein
(	O
SLP-76	B-protein
)	O
interacts	O
with	O
the	O
guanine	B-protein
nucleotide	I-protein
exchange	I-protein
factor	I-protein
Vav	B-protein
to	O
activate	O
the	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
cells	I-protein
(	O
NF-AT	B-protein
)	O
,	O
and	O
its	O
expression	O
is	O
required	O
for	O
normal	O
T	B-cell_type
cell	I-cell_type
development	O
.	O

We	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
Grb2-like	B-protein
adaptor	I-protein
molecule	I-protein
designated	O
as	O
Grb2-related	B-protein
protein	I-protein
of	I-protein
the	I-protein
lymphoid	I-protein
system	I-protein
(	O
GrpL	B-protein
)	O
.	O

Expression	O
of	O
GrpL	B-protein
is	O
restricted	O
to	O
hematopoietic	O
tissues	O
,	O
and	O
it	O
is	O
distinguished	O
from	O
Grb2	B-protein
by	O
having	O
a	O
proline-rich	B-protein
region	I-protein
.	O

GrpL	B-protein
can	O
be	O
coimmunoprecipitated	O
with	O
SLP-76	B-protein
but	O
not	O
with	O
Sos1	B-protein
or	O
Sos2	B-protein
from	O
Jurkat	B-cell_line
cell	I-cell_line
lysates	O
.	O

In	O
contrast	O
,	O
Grb2	B-protein
can	O
be	O
coimmunoprecipitated	O
with	O
Sos1	B-protein
and	O
Sos2	B-protein
but	O
not	O
with	O
SLP-76	B-protein
.	O

Moreover	O
,	O
tyrosine-phosphorylated	B-protein
LAT/pp36/38	I-protein
in	O
detergent	O
lysates	O
prepared	O
from	O
anti-CD3	B-cell_type
stimulated	I-cell_type
T	I-cell_type
cells	I-cell_type
associated	O
with	O
Grb2	B-protein
but	O
not	O
GrpL	B-protein
.	O

These	O
data	O
reveal	O
the	O
presence	O
of	O
distinct	O
complexes	O
involving	O
GrpL	B-protein
and	O
Grb2	B-protein
in	O
T	B-cell_type
cells	I-cell_type
.	O

A	O
functional	O
role	O
of	O
the	O
GrpL-SLP-76	B-protein
complex	I-protein
is	O
suggested	O
by	O
the	O
ability	O
of	O
GrpL	B-protein
to	O
act	O
alone	O
or	O
in	O
concert	O
with	O
SLP-76	B-protein
to	O
augment	O
NF-AT	B-protein
activation	O
in	O
Jurkat	B-cell_line
T	B-cell_type
cells	I-cell_type
.	O

GrpL	NULL
,	NULL
a	NULL
Grb2-related	NULL
Adaptor	NULL
Protein	NULL
,	NULL
Interacts	NULL
with	NULL
SLP-76	NULL
to	NULL
Regulate	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cell	NULL
Activation	NULL
By	NULL
Che-Leung	NULL
Law	NULL
,	NULL
*	NULL
Maria	NULL
K.	NULL
Ewings	NULL
,	NULL
*	NULL
Preet	NULL
M.	NULL
Chaudhary	NULL
,	NULL
}	NULL
Sasha	NULL
A.	NULL
Solow	NULL
,	NULL
*	NULL
Theodore	NULL
J.	NULL
Yun	NULL
,	NULL
*	NULL
Aaron	NULL
J.	NULL
Marshall	NULL
,	NULL
*	NULL
Leroy	NULL
Hood	NULL
,	NULL
#	NULL
and	NULL
Edward	NULL
A.	NULL
Clark	NULL
*	NULL
$	NULL
From	NULL
the	NULL
*Department	NULL
of	NULL
Micibiclogy	NULL
,	NULL
the	NULL
*Department	NULL
of	NULL
Molecilar	NULL
Biotechnology	NULL
,	NULL
and	NULL
the	NULL
$	NULL
R	NULL
egional	NULL
Primate	NULL
R	NULL
esearch	NULL
Center	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
Washington	NULL
98195	NULL
Summary	NULL
Propagation	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
involves	NULL
a	NULL
number	NULL
of	NULL
adaptor	NULL
molecules	NULL
.	NULL

SH2	NULL
domain-containing	NULL
protein	NULL
76	NULL
(	NULL
SLP-76	NULL
)	NULL
interacts	NULL
with	NULL
the	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
Vav	NULL
to	NULL
activate	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

We	NULL
report	NULL
the	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
Grb2-like	NULL
adaptor	NULL
molecule	NULL
designated	NULL
as	NULL
Grb2-related	NULL
protein	NULL
of	NULL
the	NULL
lymphoid	NULL
system	NULL
(	NULL
GrpL	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
GrpL	NULL
is	NULL
restricted	NULL
to	NULL
hematopoietic	NULL
tissues	NULL
,	NULL
and	NULL
it	NULL
is	NULL
distinguished	NULL
from	NULL
Grb2	NULL
by	NULL
having	NULL
a	NULL
proline-rich	NULL
region	NULL
.	NULL

GrpL	NULL
can	NULL
be	NULL
coimmunoprecipitated	NULL
with	NULL
SLP-76	NULL
but	NULL
not	NULL
with	NULL
Sos1	NULL
or	NULL
Sos2	NULL
from	NULL
Jurkat	NULL
cell	NULL
lysates	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Grb2	NULL
can	NULL
be	NULL
coimmunoprecipitated	NULL
with	NULL
Sosl	NULL
and	NULL
Sos2	NULL
but	NULL
not	NULL
with	NULL
SLP-76	NULL
.	NULL

Moreover	NULL
,	NULL
tyrosine-phosphorylated	NULL
LAT/pp36/	NULL
38	NULL
in	NULL
detergent	NULL
lysates	NULL
prepared	NULL
from	NULL
anti-CD3	NULL
stimulated	NULL
T	NULL
cells	NULL
associated	NULL
with	NULL
Grb2	NULL
but	NULL
not	NULL
GrpL	NULL
.	NULL

These	NULL
data	NULL
reveal	NULL
the	NULL
presence	NULL
of	NULL
distinct	NULL
complexes	NULL
involving	NULL
GrpL	NULL
and	NULL
Grb2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
functional	NULL
role	NULL
of	NULL
the	NULL
GrpL-SLP-76	NULL
complex	NULL
is	NULL
suggested	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
GrpL	NULL
to	NULL
act	NULL
alone	NULL
or	NULL
in	NULL
concert	NULL
with	NULL
SLP-76	NULL
to	NULL
augment	NULL
NF-AT	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
Ligation	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
complex	NULL
activates	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
'	NULL
including	NULL
the	NULL
Src	NULL
family	NULL
PTKs	NULL
Fyn	NULL
and	NULL
Leck	NULL
to	NULL
phosphorylate	NULL
immuno-receptor	NULL
tyrosine-based	NULL
motifs	NULL
(	NULL
ITAMs	NULL
)	NULL
within	NULL
associating	NULL
CD3	NULL
chains	NULL
.	NULL

This	NULL
leads	NULL
to	NULL
the	NULL
recruitment	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
Syk	NULL
family	NULL
kinase	NULL
ZAP-70	NULL
and	NULL
possibly	NULL
other	NULL
proteins	NULL
such	NULL
as	NULL
She	NULL
to	NULL
phosphorylated	NULL
CD3L	NULL
.	NULL

These	NULL
activated	NULL
PTKs	NULL
in	NULL
turn	NULL
phosphorylate	NULL
a	NULL
variety	NULL
of	NULL
proteins	NULL
,	NULL
and	NULL
thereby	NULL
couple	NULL
TCR	NULL
ligation	NULL
to	NULL
a	NULL
number	NULL
of	NULL
intracellular	NULL
signaling	NULL
cascades	NULL
culminating	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Principal	NULL
downstream	NULL
substrates/	NULL
effectors	NULL
for	NULL
TCR	NULL
-activated	NULL
PTKs	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

They	NULL
include	NULL
phospholipase	NULL
C-y1	NULL
(	NULL
1-3	NULL
)	NULL
,	NULL
the	NULL
85-kD	NULL
subunit	NULL
of	NULL
the	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
src	NULL
homology	NULL
(	NULL
SH	NULL
)	NULL
2	NULL
domain-containing	NULL
leukocyte	NULL
protein	NULL
C.-L.	NULL
Law	NULL
,	NULL
MK	NULL
.	NULL

Ewings	NULL
,	NULL
and	NULL
P.M.	NULL
Chaudhary	NULL
all	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
study	NULL
.	NULL
'	NULL

A	NULL
bbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
GEF	NULL
,	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
;	NULL
GrpL	NULL
,	NULL
Grb2-related	NULL
protein	NULL
of	NULL
the	NULL
lymphoid	NULL
system	NULL
;	NULL
IP	NULL
,	NULL
immunoprecipi-tate	NULL
,	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
NF-AT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
PTK	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
;	NULL
SH	NULL
,	NULL
src	NULL
homology	NULL
;	NULL
SHP	NULL
,	NULL
SH2	NULL
domain-containing	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
;	NULL
SLP-76	NULL
,	NULL
SH2	NULL
domain-containing	NULL
leukocyte	NULL
protein	NULL
of	NULL
76	NULL
kD	NULL
.	NULL

1243	NULL
GrpL	NULL
«	NULL
SLP-76	NULL
«	NULL
Grb2	NULL
«	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
cells	NULL
»	NULL
cell	NULL
activation	NULL
of	NULL
76	NULL
kD	NULL
(	NULL
SLP-76	NULL
)	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
the	NULL
proto-oncogene	NULL
product	NULL
Cbl	NULL
(	NULL
5	NULL
,	NULL
7	NULL
)	NULL
,	NULL
the	NULL
Vav	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
(	NULL
GEF	NULL
)	NULL
of	NULL
the	NULL
R	NULL
ho/R	NULL
ac/CDC42	NULL
family	NULL
of	NULL
GTP-binding	NULL
proteins	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
and	NULL
the	NULL
recently	NULL
cloned	NULL
and	NULL
characterized	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
LAT/pp36/	NULL
38	NULL
)	NULL
(	NULL
10-14	NULL
)	NULL
.	NULL

Functional	NULL
interactions	NULL
between	NULL
these	NULL
phosphorylated	NULL
effector	NULL
molecules	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
the	NULL
operation	NULL
of	NULL
major	NULL
pathways	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
maturation	NULL
including	NULL
(	NULL
a	NULL
)	NULL
intracellular	NULL
free	NULL
Ca	NULL
?	NULL

+	NULL
release	NULL
,	NULL
(	NULL
b	NULL
)	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
,	NULL
and	NULL
(	NULL
c	NULL
)	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
activation	NULL
.	NULL

These	NULL
events	NULL
ultimately	NULL
converge	NULL
to	NULL
induce	NULL
gene	NULL
expression	NULL
,	NULL
proliferation	NULL
,	NULL
or	NULL
differentiation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

SLP-76	NULL
is	NULL
an	NULL
essential	NULL
adaptor	NULL
molecule	NULL
in	NULL
T	NULL
cells	NULL
When	NULL
it	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
,	NULL
probably	NULL
by	NULL
ZAP-70	NULL
,	NULL
SLP-76	NULL
may	NULL
become	NULL
a	NULL
ligand	NULL
for	NULL
Vav	NULL
(	NULL
9	NULL
,	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
tyrosine-phosphorylated	NULL
SLP-76-Vav	NULL
complex	NULL
augments	NULL
TCR	NULL
-induced	NULL
activation	NULL
of	NULL
NF-AT	NULL
,	NULL
and	NULL
hence	NULL
expression	NULL
of	NULL
IL-2	NULL
(	NULL
9	NULL
,	NULL
18-21	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vivo	NULL
function	NULL
of	NULL
SLP-76	NULL
in	NULL
T	NULL
lineage	NULL
cells	NULL
is	NULL
further	NULL
illustrated	NULL
by	NULL
recent	NULL
studies	NULL
of	NULL
SLP-76-deficient	NULL
mice	NULL
.	NULL

Mice	NULL
deficient	NULL
in	NULL
SLP-76	NULL
expression	NULL
show	NULL
profound	NULL
defects	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
and	NULL
contain	NULL
no	NULL
CD4/	NULL
CD8	NULL
double	NULL
positive	NULL
thymocytes	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
complete	NULL
loss	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/99/	NULL
04/	NULL
1243/11	NULL
$	NULL
2.00	NULL
Volume	NULL
189	NULL
,	NULL
Number	NULL
8	NULL
,	NULL
April	NULL
19	NULL
,	NULL
1999	NULL
1243-1253	NULL
http	NULL
:	NULL
//	NULL
www.jem.org	NULL
One	NULL
connection	NULL
between	NULL
the	NULL
TCR	NULL
and	NULL
SLP-76	NULL
may	NULL
be	NULL
provided	NULL
by	NULL
Grb2	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
SH2	NULL
domain	NULL
of	NULL
Grb2	NULL
binds	NULL
to	NULL
both	NULL
She	NULL
and	NULL
LAT/pp36/	NULL
38	NULL
,	NULL
allowing	NULL
Grb2	NULL
to	NULL
be	NULL
localized	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
where	NULL
most	NULL
of	NULL
the	NULL
TCR	NULL
-activated	NULL
PTKs	NULL
are	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
SH3	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
of	NULL
Grb2	NULL
bind	NULL
to	NULL
Sos	NULL
!	NULL

and	NULL
Sos	NULL
?	NULL

(	NULL
GEF	NULL
of	NULL
the	NULL
R	NULL
as	NULL
family	NULL
of	NULL
GTP-binding	NULL
pro-tein	NULL
)	NULL
(	NULL
26	NULL
)	NULL
,	NULL
SLP-76	NULL
(	NULL
21	NULL
,	NULL
27	NULL
)	NULL
,	NULL
and	NULL
Cbl	NULL
(	NULL
7	NULL
,	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
recruitment	NULL
of	NULL
Sos	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
by	NULL
Grb2	NULL
initiates	NULL
the	NULL
MAPK	NULL
pathway	NULL
,	NULL
whereas	NULL
the	NULL
recruitment	NULL
of	NULL
SLP-76	NULL
(	NULL
30	NULL
)	NULL
,	NULL
Vav	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
and	NULL
Cbl	NULL
(	NULL
7	NULL
,	NULL
31	NULL
,	NULL
32	NULL
)	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
probably	NULL
facilitates	NULL
their	NULL
phosphorylation	NULL
by	NULL
TCR	NULL
-activated	NULL
PTK	NULL
.	NULL

The	NULL
studies	NULL
above	NULL
suggest	NULL
that	NULL
Grb2	NULL
may	NULL
function	NULL
to	NULL
link	NULL
multiple	NULL
downstream	NULL
effector	NULL
molecules	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
SLP-76	NULL
,	NULL
to	NULL
LAT	NULL
and	NULL
possibly	NULL
to	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
activated	NULL
TCR	NULL
complex	NULL
.	NULL

However	NULL
,	NULL
more	NULL
recent	NULL
studies	NULL
have	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
additional	NULL
Grb2-like	NULL
adaptor	NULL
molecule	NULL
,	NULL
Grap	NULL
,	NULL
which	NULL
has	NULL
the	NULL
SH3-SH2-SH3	NULL
organization	NULL
as	NULL
Grb2	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
expression	NULL
of	NULL
Grap	NULL
appears	NULL
to	NULL
be	NULL
relatively	NULL
restricted	NULL
to	NULL
hematopoietic	NULL
tissues	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Besides	NULL
binding	NULL
to	NULL
c-kit	NULL
,	NULL
the	NULL
Ber-	NULL
oncoprotein	NULL
,	NULL
and	NULL
the	NULL
erythro-poietin	NULL
receptor	NULL
,	NULL
Grap	NULL
also	NULL
interacts	NULL
with	NULL
LAT/pp36/	NULL
38	NULL
,	NULL
Sos	NULL
,	NULL
She	NULL
,	NULL
and	NULL
phospholipase	NULL
C-y1	NULL
in	NULL
TCR	NULL
-activated	NULL
Jurkat	NULL
cells	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Exactly	NULL
how	NULL
Grb2	NULL
and	NULL
Grap	NULL
coordinate	NULL
their	NULL
functions	NULL
during	NULL
TCR	NULL
signaling	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
report	NULL
the	NULL
molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
another	NULL
linker	NULL
protein	NULL
,	NULL
which	NULL
shares	NULL
a	NULL
number	NULL
of	NULL
structural	NULL
properties	NULL
with	NULL
Grb2	NULL
and	NULL
Grap	NULL
,	NULL
yet	NULL
differs	NULL
from	NULL
them	NULL
by	NULL
having	NULL
a	NULL
proline-rich	NULL
region	NULL
.	NULL

Since	NULL
transcripts	NULL
encoding	NULL
this	NULL
linker	NULL
protein	NULL
appear	NULL
to	NULL
be	NULL
preferentially	NULL
expressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
designated	NULL
this	NULL
protein	NULL
GrpL	NULL
,	NULL
for	NULL
Grb2-related	NULL
protein	NULL
of	NULL
the	NULL
lymphoid	NULL
system	NULL
.	NULL

GrpL	NULL
associates	NULL
with	NULL
different	NULL
effector	NULL
molecules	NULL
than	NULL
does	NULL
Grb2	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
it	NULL
regulates	NULL
TCR	NULL
-induced	NULL
NF-	NULL
AT	NULL
activation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
and	NULL
A	NULL
ntibodies	NULL
.	NULL

_	NULL
Various	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
standard	NULL
culture	NULL
media	NULL
supplemented	NULL
with	NULL
L-glutamine	NULL
,	NULL
nonessential	NULL
amino	NULL
acids	NULL
,	NULL
sodium	NULL
pyruvate	NULL
,	NULL
penicillin/	NULL
streptomycin	NULL
,	NULL
and	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

A	NULL
rabbit	NULL
anti-human	NULL
(	NULL
bh	NULL
)	NULL
GrpL	NULL
serum	NULL
was	NULL
generated	NULL
in	NULL
this	NULL
study	NULL
against	NULL
a	NULL
His-	NULL
Tag	NULL
fusion	NULL
protein	NULL
containing	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
hGrpL	NULL
as	NULL
described	NULL
below	NULL
.	NULL

Antiphosphotyrosine	NULL
4G10	NULL
and	NULL
anti-LAT/pp36/	NULL
38	NULL
were	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
Anti-SLP-76	NULL
,	NULL
anti-Grb2	NULL
,	NULL
anti-SH2	NULL
domain-containing	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
2	NULL
(	NULL
SHP-2	NULL
)	NULL
,	NULL
anti-	NULL
and	NULL
anti-	NULL
Sos2	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

64.1	NULL
(	NULL
anti-CD3	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
John	NULL
Hansen	NULL
(	NULL
Fred	NULL
Hutchinson	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
,	NULL
C305	NULL
(	NULL
anti-TCR	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
G.	NULL
Koretzky	NULL
(	NULL
University	NULL
of	NULL
Iowa	NULL
,	NULL
Iowa	NULL
City	NULL
,	NULL
IA	NULL
)	NULL
,	NULL
and	NULL
OKT	NULL
3	NULL
(	NULL
anti-CD3	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
Full-Length	NULL
DNA	NULL
Clones	NULL
Encoding	NULL
Human	NULL
and	NULL
Murine	NULL
GL	NULL
.	NULL

_	NULL
A	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
hGrpL	NULL
was	NULL
identified	NULL
through	NULL
random	NULL
sequencing	NULL
of	NULL
clones	NULL
from	NULL
a	NULL
library	NULL
prepared	NULL
from	NULL
the	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
cell	NULL
line	NULL
KG-1a	NULL
.	NULL

O	NULL
verlapping	NULL
partial	NULL
cDN	NULL
A	NULL
clones	NULL
encoding	NULL
murine	NULL
(	NULL
m	NULL
)	NULL
GrpL	NULL
were	NULL
isolated	NULL
by	NULL
low	NULL
stringency	NULL
reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
-PCR	NULL
using	NULL
multiple	NULL
hGrpL-specific	NULL
primer	NULL
sets	NULL
and	NULL
murine	NULL
splenic	NULL
total	NULL
RNA	NULL
as	NULL
the	NULL
template	NULL
.	NULL

RT-PCR	NULL
at	NULL
low	NULL
annealing	NULL
temperature	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
Titan	NULL
``	NULL
One	NULL
Tube	NULL
RT-PCR	NULL
1244	NULL
System	NULL
protocol	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Inc.	NULL
)	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
1.5	NULL
%	NULL
agarose	NULL
gels	NULL
.	NULL

cDN	NULL
A	NULL
bands	NULL
corresponding	NULL
in	NULL
sizes	NULL
to	NULL
the	NULL
estimated	NULL
lengths	NULL
of	NULL
hGrpL	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
and	NULL
eluded	NULL
using	NULL
the	NULL
QIAEX	NULL
II	NULL
Gel	NULL
Extraction	NULL
Kit	NULL
(	NULL
QIAGEN	NULL
Inc.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
suppliers	NULL
protocol	NULL
.	NULL

Isolated	NULL
cDN	NULL
As	NULL
were	NULL
then	NULL
ligated	NULL
into	NULL
a	NULL
T/	NULL
A	NULL
cloning	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
and	NULL
transformed	NULL
into	NULL
competent	NULL
E.	NULL
oli	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

Recombi-nant	NULL
clones	NULL
containing	NULL
mGrpL	NULL
inserts	NULL
were	NULL
selected	NULL
by	NULL
low	NULL
stringency	NULL
hybridization	NULL
to	NULL
a	NULL
hGrpL	NULL
cDNA	NULL
probe	NULL
and	NULL
then	NULL
sequenced	NULL
.	NULL

This	NULL
allowed	NULL
for	NULL
the	NULL
identification	NULL
of	NULL
primer	NULL
sets	NULL
specific	NULL
for	NULL
mGrpL	NULL
for	NULL
the	NULL
isolation	NULL
of	NULL
cDNA	NULL
clones	NULL
encoding	NULL
both	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
mGrpL	NULL
by	NULL
rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
ends	NULL
.	NULL

The	NULL
gene	NULL
specific	NULL
primers	NULL
chosen	NULL
were	NULL
:	NULL
5	NULL
'	NULL
cDNA	NULL
end	NULL
,	NULL
5'-CTG	NULL
AGC	NULL
TTT	NULL
CGC	NULL
ACT	NULL
GGA	NULL
GAC	NULL
ATT	NULL
CTG	NULL
;	NULL
3	NULL
'	NULL
cDNA	NULL
end	NULL
,	NULL
TCA	NULL
GCG	NULL
TGG	NULL
CGT	NULL
TCA	NULL
CCT	NULL
CAC	NULL
TTC	NULL
C.	NULL
The	NULL
Marathon-Ready	NULL
``	NULL
``	NULL
cDNA	NULL
kit	NULL
(	NULL
Clontech	NULL
Laboratory	NULL
Inc.	NULL
)	NULL
was	NULL
used	NULL
for	NULL
RACE	NULL
PCR	NULL
and	NULL
performed	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
supplier	NULL
.	NULL

The	NULL
resulting	NULL
PCR	NULL
products	NULL
were	NULL
cloned	NULL
into	NULL
T/	NULL
A	NULL
cloning	NULL
vectors	NULL
(	NULL
Invitrogen	NULL
)	NULL
and	NULL
sequenced	NULL
.	NULL

Plasmid	NULL
Construds	NULL
.	NULL

-	NULL
To	NULL
generate	NULL
the	NULL
GrpL	NULL
SH2	NULL
His-	NULL
Tag	NULL
fusion	NULL
protein	NULL
,	NULL
PCR	NULL
was	NULL
used	NULL
to	NULL
amplify	NULL
a	NULL
piece	NULL
of	NULL
cDNA	NULL
encoding	NULL
the	NULL
SH2	NULL
domains	NULL
of	NULL
GrpL	NULL
using	NULL
the	NULL
full-length	NULL
GrpL	NULL
cDNA	NULL
as	NULL
template	NULL
and	NULL
the	NULL
following	NULL
primer	NULL
pairs	NULL
:	NULL
forward	NULL
primer	NULL
,	NULL
5-GCG	NULL
GGG	NULL
ATC	NULL
CCC	NULL
CAG	NULL
TTT	NULL
CCC	NULL
AAA	NULL
TGG	NULL
TTT	NULL
CAC	NULL
;	NULL
reverse	NULL
primer	NULL
,	NULL
5-GCG	NULL
GGG	NULL
AAT	NULL
TCC	NULL
TCT	NULL
GTC	NULL
TCT	NULL
AAG	NULL
GAA	NULL
GAT	NULL
CTG	NULL
.	NULL

Underlined	NULL
nucleotides	NULL
represent	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
sites	NULL
in	NULL
the	NULL
forward	NULL
and	NULL
reverse	NULL
primers	NULL
,	NULL
respectively	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
cut	NULL
with	NULL
these	NULL
enzymes	NULL
and	NULL
ligated	NULL
into	NULL
BamHI/	NULL
EcoRI	NULL
cut	NULL
pET	NULL
-28c	NULL
(	NULL
+	NULL
)	NULL
(	NULL
Novagen	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
GST	NULL
fusion	NULL
construct	NULL
,	NULL
the	NULL
insert	NULL
from	NULL
the	NULL
His	NULL
Tag	NULL
fusion	NULL
construct	NULL
was	NULL
cut	NULL
out	NULL
by	NULL
BamHI/	NULL
EcoRI	NULL
and	NULL
subcloned	NULL
into	NULL
BamHI	NULL
EcoRI	NULL
cut	NULL
pGEX-5X-2	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

The	NULL
fusion	NULL
protein	NULL
constructs	NULL
were	NULL
then	NULL
transformed	NULL
into	NULL
E.	NULL
off	NULL
strain	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
and	NULL
induced	NULL
with	NULL
IPTG	NULL
for	NULL
protein	NULL
production	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
Myc-His	NULL
tagged	NULL
hGrpL	NULL
expression	NULL
plasmid	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
hGrpL	NULL
was	NULL
amplified	NULL
using	NULL
the	NULL
following	NULL
primer	NULL
pairs	NULL
:	NULL
forward	NULL
primer	NULL
,	NULL
GAA	NULL
GCT	NULL
CGA	NULL
GTC	NULL
GGG	NULL
TCA	NULL
TGG	NULL
GTG	NULL
CCA	NULL
CGT	NULL
A	NULL
;	NULL
reverse	NULL
primer	NULL
,	NULL
5-GCG	NULL
GAA	NULL
TTC	NULL
GGA	NULL
GGA	NULL
TGG	NULL
AAG	NULL
CTG	NULL
TTG	NULL
CCA	NULL
AGT	NULL
TT	NULL
.	NULL

Underlined	NULL
nucleotides	NULL
represent	NULL
Xhol	NULL
and	NULL
EcoRI	NULL
sites	NULL
in	NULL
the	NULL
forward	NULL
and	NULL
reverse	NULL
primers	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
pcDNA3.1	NULL
(	NULL
+	NULL
)	NULL
/	NULL
Myc-His	NULL
A	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
,	NULL
in-frame	NULL
with	NULL
the	NULL
c-Myc	NULL
epitope	NULL
and	NULL
poly-His	NULL
tags	NULL
.	NULL

The	NULL
hGrpL-Myc-His	NULL
cassette	NULL
was	NULL
then	NULL
excised	NULL
with	NULL
BamHI	NULL
and	NULL
PmelI	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
pEF	NULL
expression	NULL
vector	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
G.	NULL
Koretzky	NULL
)	NULL
at	NULL
the	NULL
BamHI	NULL
and	NULL
filled-in	NULL
Xbal	NULL
sites	NULL
(	NULL
pEF-GrpL	NULL
)	NULL
.	NULL

The	NULL
pEF-SLP-76	NULL
and	NULL
the	NULL
NF-AT	NULL
luciferase	NULL
reporter	NULL
(	NULL
NF-AT	NULL
Luc	NULL
)	NULL
constructs	NULL
were	NULL
also	NULL
gifts	NULL
from	NULL
Dr.	NULL
G.	NULL
Koretzky	NULL
.	NULL

Northem	NULL
Blot	NULL
Analysis	NULL
and	NULL
RT-PCR	NULL
.	NULL

-	NULL
To	NULL
detect	NULL
GrpL	NULL
message	NULL
in	NULL
cell	NULL
lines	NULL
,	NULL
~30	NULL
ug	NULL
of	NULL
RNA	NULL
were	NULL
resolved	NULL
on	NULL
1.2	NULL
%	NULL
morpholine	NULL
propanesulfonic	NULL
acid	NULL
(	NULL
MOPS	NULL
)	NULL
formaldehyde	NULL
agarose	NULL
gels	NULL
,	NULL
trans	NULL
ferred	NULL
onto	NULL
GeneScreen	NULL
Plus	NULL
membranes	NULL
(	NULL
NEN	NULL
**	NULL
Life	NULL
Science	NULL
Products	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
fixed	NULL
by	NULL
UV	NULL
cross-linking	NULL
.	NULL

Multiple	NULL
tissue	NULL
Northern	NULL
blots	NULL
were	NULL
obtained	NULL
from	NULL
Clontech	NULL
.	NULL

Northern	NULL
blots	NULL
were	NULL
prehybridized	NULL
and	NULL
hybridized	NULL
to	NULL
either	NULL
the	NULL
full-length	NULL
GrpL	NULL
cDNA	NULL
or	NULL
B-actin	NULL
probes	NULL
labeled	NULL
with	NULL
a-	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
(	NULL
NEN	NULL
**	NULL
Life	NULL
Science	NULL
Products	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

RT-PCR	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Titan	NULL
``	NULL
One	NULL
Tube	NULL
RT-PCR	NULL
System	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
1	NULL
jg	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
20	NULL
nM	NULL
forward	NULL
and	NULL
reverse	NULL
primers	NULL
.	NULL

Primers	NULL
used	NULL
were	NULL
:	NULL
forward	NULL
primer	NULL
,	NULL
5'-TGG	NULL
AAG	NULL
CTG	NULL
TTG	NULL
CCA	NULL
AGT	NULL
TTG	NULL
ATT	NULL
TCA	NULL
C	NULL
;	NULL
reverse	NULL
primer	NULL
,	NULL
5-CTT	NULL
CTC	NULL
GGG	NULL
TTC	NULL
TGT	NULL
CTC	NULL
TAA	NULL
GGA	NULL
AG	NULL
.	NULL

Novel	NULL
Adaptor	NULL
Molecule	NULL
That	NULL
Regulates	NULL
NF-AT	NULL
Activation	NULL
This	NULL
primer	NULL
set	NULL
amplifies	NULL
a	NULL
452-bp	NULL
fragment	NULL
containing	NULL
the	NULL
NH-terminal	NULL
SH3	NULL
and	NULL
the	NULL
SH2	NULL
domains	NULL
from	NULL
cells	NULL
expressing	NULL
GrpL	NULL
message	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
total	NULL
RNA	NULL
used	NULL
was	NULL
monitored	NULL
by	NULL
amplification	NULL
of	NULL
a	NULL
1-kb	NULL
fragment	NULL
encoding	NULL
G3DPH	NULL
using	NULL
the	NULL
following	NULL
primer	NULL
set	NULL
:	NULL
forward	NULL
primer	NULL
,	NULL
5'-TGA	NULL
AGG	NULL
TCG	NULL
GAG	NULL
TCA	NULL
ACG	NULL
GAT	NULL
TTG	NULL
GT	NULL
;	NULL
reverse	NULL
primer	NULL
,	NULL
5'-CAT	NULL
GTG	NULL
GGC	NULL
CAT	NULL
GAG	NULL
GTC	NULL
CAC	NULL
CAC	NULL
.	NULL

Cycling	NULL
parameters	NULL
PCR	NULL
were	NULL
programmed	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
provided	NULL
with	NULL
the	NULL
Titan	NULL
*	NULL
``	NULL
system	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

T	NULL
Cell	NULL
Stimulation	NULL
,	NULL
Immucpredpitation	NULL
,	NULL
and	NULL
Immunoblot	NULL
Analysis	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
at	NULL
5-10	NULL
%	NULL
10	NULL
%	NULL
ml	NULL
in	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
equilibrate	NULL
at	NULL
37°C	NULL
for	NULL
15	NULL
min	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
either	NULL
5	NULL
or	NULL
10	NULL
pg/ml	NULL
of	NULL
anti-CD3	NULL
or	NULL
2.5	NULL
mM	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
250	NULL
M	NULL
of	NULL
sodium	NULL
orthovanadate	NULL
(	NULL
referred	NULL
to	NULL
as	NULL
pervanadate	NULL
)	NULL
.	NULL

Either	NULL
class	NULL
matched	NULL
antibodies	NULL
or	NULL
medium	NULL
only	NULL
was	NULL
used	NULL
as	NULL
control	NULL
stimulus	NULL
.	NULL

Stimulation	NULL
was	NULL
terminated	NULL
by	NULL
dilution	NULL
of	NULL
cell	NULL
suspensions	NULL
into	NULL
>	NULL
10	NULL
vol	NULL
of	NULL
ice-cold	NULL
PBS	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
and	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
NP-40	NULL
,	NULL
protease	NULL
inhibitors	NULL
(	NULL
2	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
g/	NULL
ml	NULL
aprotinin	NULL
,	NULL
10	NULL
g/	NULL
ml	NULL
leupeptin	NULL
,	NULL
and	NULL
1	NULL
g/	NULL
ml	NULL
pepstatin	NULL
)	NULL
,	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
NaVO	NULL
,	NULL
,	NULL
and	NULL
5	NULL
mM	NULL
Na	NULL
,	NULL
P	NULL
;	NULL
,0	NULL
;	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
before	NULL
immunoprecipitation	NULL
.	NULL

Immunoprecipitation	NULL
,	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
were	NULL
conducted	NULL
as	NULL
described	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
primary	NULL
antibodies	NULL
to	NULL
blots	NULL
was	NULL
detected	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
antibodies	NULL
or	NULL
streptavidin	NULL
(	NULL
Jackson	NULL
ImmunoResearch	NULL
Labs	NULL
.	NULL
)	NULL

and	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
kit	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

T	NULL
Cell	NULL
T	NULL
rnsfection	NULL
and	NULL
Ludferase	NULL
Assays	NULL
.	NULL

-	NULL
Jurkat	NULL
cells	NULL
in	NULL
log-phase	NULL
were	NULL
washed	NULL
with	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
once	NULL
and	NULL
elec-troporated	NULL
in	NULL
triplicate	NULL
with	NULL
a	NULL
total	NULL
of	NULL
60	NULL
pg	NULL
of	NULL
plasmid	NULL
at	NULL
240	NULL
V	NULL
,	NULL
960	NULL
F	NULL
using	NULL
a	NULL
Gene	NULL
Pulser	NULL
(	NULL
Bio-	NULL
R	NULL
ad	NULL
)	NULL
at	NULL
10	NULL
``	NULL
cells	NULL
400	NULL
pl	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
.	NULL

In	NULL
general	NULL
,	NULL
20	NULL
pg	NULL
of	NULL
NF-AT	NULL
Luc	NULL
were	NULL
cotrans-fected	NULL
with	NULL
either	NULL
20	NULL
pug	NULL
of	NULL
pEF	NULL
,	NULL
pEF-SLP-76	NULL
,	NULL
pEF-GrpL	NULL
,	NULL
or	NULL
pEF-SLP-76	NULL
plus	NULL
pEF-GrpL	NULL
.	NULL

Sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
was	NULL
used	NULL
to	NULL
maintain	NULL
the	NULL
total	NULL
DN	NULL
A	NULL
at	NULL
60	NULL
ug	NULL
whenever	NULL
necessary	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
fully	NULL
supplemented	NULL
RPMI	NULL
1640	NULL
for	NULL
14-18	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
,	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
transferred	NULL
into	NULL
96-well	NULL
plates	NULL
at	NULL
2-5	NULL
X	NULL
10°	NULL
celly	NULL
well	NULL
in	NULL
a	NULL
total	NULL
of	NULL
100	NULL
pl	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
in	NULL
triplicate	NULL
with	NULL
1:500	NULL
dilution	NULL
of	NULL
C305	NULL
anti-CD3	NULL
for	NULL
6-8	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Control	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
culture	NULL
medium	NULL
.	NULL

After	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
50-100	NULL
pl	NULL
Reporter	NULL
Lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
quantified	NULL
by	NULL
adding	NULL
10	NULL
pl	NULL
of	NULL
the	NULL
lysate	NULL
to	NULL
50	NULL
pul	NULL
of	NULL
luciferase	NULL
assay	NULL
substrate	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
immediately	NULL
measured	NULL
with	NULL
a	NULL
GenProbe	NULL
Leader	NULL
``	NULL
1	NULL
luminometer	NULL
(	NULL
Wallac	NULL
Inc.	NULL
)	NULL
.	NULL

To	NULL
normalize	NULL
for	NULL
variations	NULL
in	NULL
transfection	NULL
efficiency	NULL
,	NULL
luciferase	NULL
activities	NULL
in	NULL
different	NULL
transfection	NULL
conditions	NULL
were	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
maximal	NULL
NF-AT	NULL
responses	NULL
determined	NULL
by	NULL
treating	NULL
cells	NULL
with	NULL
50	NULL
ng/ml	NULL
PMA	NULL
and	NULL
1	NULL
M	NULL
ionomycin	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Results	NULL
Identification	NULL
of	NULL
GmpL	NULL
,	NULL
a	NULL
New	NULL
Member	NULL
of	NULL
the	NULL
G	NULL
Family	NULL
of	NULL
Adaptor	NULL
Proteins	NULL
.	NULL

Through	NULL
random	NULL
sequencing	NULL
of	NULL
cDNA	NULL
clones	NULL
in	NULL
a	NULL
library	NULL
prepared	NULL
from	NULL
the	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
cell	NULL
line	NULL
KG-1a	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
cDNA	NULL
encoding	NULL
a	NULL
330-amino	NULL
acid	NULL
polypeptide	NULL
with	NULL
a	NULL
predicted	NULL
molecular	NULL
weight	NULL
of	NULL
~37	NULL
kD	NULL
.	NULL

The	NULL
linear	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
this	NULL
polypeptide	NULL
organizes	NULL
into	NULL
an	NULL
NH-terminal	NULL
SH3	NULL
domain	NULL
1245	NULL
Law	NULL
et	NULL
al	NULL
.	NULL

followed	NULL
by	NULL
an	NULL
SH2	NULL
domain	NULL
,	NULL
a	NULL
proline-rich	NULL
region	NULL
,	NULL
and	NULL
finally	NULL
a	NULL
COOH-terminal	NULL
SH3	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

A	NULL
comparison	NULL
to	NULL
other	NULL
known	NULL
proteins	NULL
available	NULL
in	NULL
current	NULL
sequence	NULL
data	NULL
banks	NULL
revealed	NULL
that	NULL
this	NULL
protein	NULL
is	NULL
most	NULL
similar	NULL
to	NULL
the	NULL
adaptor	NULL
proteins	NULL
,	NULL
Grb2	NULL
and	NULL
Grap	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
this	NULL
similarity	NULL
,	NULL
we	NULL
have	NULL
designated	NULL
this	NULL
molecule	NULL
,	NULL
GrpL	NULL
for	NULL
Grb2-related	NULL
protein	NULL
of	NULL
the	NULL
lymphoid	NULL
system	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Using	NULL
RT-PCR	NULL
and	NULL
a	NULL
combination	NULL
of	NULL
5'-	NULL
and	NULL
3'-RACE	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
,	NULL
we	NULL
also	NULL
isolated	NULL
the	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
the	NULL
murine	NULL
homologue	NULL
of	NULL
GrpL	NULL
.	NULL

Human	NULL
and	NULL
murine	NULL
GrpL	NULL
are	NULL
highly	NULL
conserved	NULL
proteins	NULL
sharing	NULL
>	NULL
90	NULL
%	NULL
identity	NULL
in	NULL
the	NULL
SH3	NULL
and	NULL
SH2	NULL
domains	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
least	NULL
conserved	NULL
area	NULL
is	NULL
the	NULL
proline-rich	NULL
region	NULL
with	NULL
~74	NULL
%	NULL
identity	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Amino	NULL
acid	NULL
sequence	NULL
alignment	NULL
between	NULL
hGrpL	NULL
,	NULL
Grb2	NULL
,	NULL
and	NULL
Grap	NULL
revealed	NULL
that	NULL
hGrpL	NULL
is	NULL
38-56	NULL
%	NULL
identical	NULL
to	NULL
Grb2	NULL
and	NULL
Grap	NULL
in	NULL
the	NULL
SH3	NULL
and	NULL
SH2	NULL
domains	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

This	NULL
conservation	NULL
is	NULL
slightly	NULL
less	NULL
than	NULL
that	NULL
between	NULL
Grb2	NULL
and	NULL
Grap	NULL
(	NULL
49-68	NULL
%	NULL
;	NULL
reference	NULL
33	NULL
)	NULL
.	NULL

The	NULL
biggest	NULL
difference	NULL
between	NULL
GrpL	NULL
and	NULL
Grb2	NULL
or	NULL
Grap	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
proline-rich	NULL
region	NULL
between	NULL
the	NULL
SH2	NULL
and	NULL
COOH-terminal	NULL
SH3	NULL
domain	NULL
.	NULL

This	NULL
proline-rich	NULL
region	NULL
could	NULL
potentially	NULL
be	NULL
bound	NULL
by	NULL
SH3	NULL
domain-containing	NULL
proteins	NULL
found	NULL
in	NULL
other	NULL
adaptor	NULL
molecules	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
amino	NULL
acid	NULL
composition	NULL
of	NULL
GrpL	NULL
suggests	NULL
that	NULL
it	NULL
may	NULL
interact	NULL
with	NULL
different	NULL
proteins	NULL
in	NULL
lymphocytes	NULL
when	NULL
compared	NULL
with	NULL
Grb2	NULL
or	NULL
Grap	NULL
.	NULL

T	NULL
ransaipts	NULL
of	NULL
GipL	NULL
Are	NULL
Seecively	NULL
Expressed	NULL
in	NULL
Hematopoietic	NULL
Tissues	NULL
and	NULL
in	NULL
B	NULL
and	NULL
T	NULL
Lymphocytes	NULL
.	NULL

-	NULL
The	NULL
transcripts	NULL
for	NULL
Grb2	NULL
are	NULL
expressed	NULL
ubiquitously	NULL
in	NULL
mammalian	NULL
species	NULL
(	NULL
38	NULL
)	NULL
,	NULL
whereas	NULL
Grap	NULL
mRNA	NULL
is	NULL
expressed	NULL
at	NULL
considerably	NULL
higher	NULL
levels	NULL
in	NULL
lymphoid	NULL
tissues	NULL
than	NULL
in	NULL
other	NULL
tissues	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
mRNA	NULL
isolated	NULL
from	NULL
different	NULL
human	NULL
tissues	NULL
demonstrated	NULL
that	NULL
the	NULL
transcripts	NULL
for	NULL
GrpL	NULL
are	NULL
relatively	NULL
restricted	NULL
to	NULL
hematopoietic	NULL
tissues	NULL
Thus	NULL
,	NULL
transcripts	NULL
of	NULL
1.4	NULL
kb	NULL
and	NULL
3-3.5	NULL
kb	NULL
were	NULL
detected	NULL
in	NULL
lymph	NULL
node	NULL
,	NULL
bone	NULL
marrow	NULL
,	NULL
spleen	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
weakly	NULL
in	NULL
testis	NULL
,	NULL
but	NULL
not	NULL
in	NULL
stomach	NULL
,	NULL
thyroid	NULL
,	NULL
spinal	NULL
cord	NULL
,	NULL
trachea	NULL
,	NULL
adrenal	NULL
gland	NULL
,	NULL
prostate	NULL
,	NULL
ovary	NULL
,	NULL
or	NULL
small	NULL
intestine	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

Probing	NULL
total	NULL
RNA	NULL
from	NULL
a	NULL
panel	NULL
of	NULL
cell	NULL
lines	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
and	NULL
RT-PCR	NULL
further	NULL
confirmed	NULL
the	NULL
restricted	NULL
expression	NULL
pattern	NULL
of	NULL
GrpL	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

GrpL	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
myeloid	NULL
and	NULL
erythroid	NULL
progenitor	NULL
cell	NULL
lines	NULL
KG-1a	NULL
and	NULL
K562	NULL
,	NULL
respectively	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
myeloid	NULL
cell	NULL
line	NULL
HL60	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
GrpL	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
Jurkat	NULL
,	NULL
Molt-4	NULL
,	NULL
HSB-2	NULL
,	NULL
CEM	NULL
,	NULL
and	NULL
HPB-	NULL
ALL	NULL
lines	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
HuT	NULL
78	NULL
line	NULL
.	NULL

Interestingly	NULL
,	NULL
of	NULL
all	NULL
the	NULL
B	NULL
cell	NULL
lines	NULL
examined	NULL
,	NULL
GrpL	NULL
transcripts	NULL
were	NULL
only	NULL
found	NULL
in	NULL
EBV-transformed	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
including	NULL
T5-1	NULL
,	NULL
HCLL7678	NULL
,	NULL
CESS	NULL
,	NULL
F4	NULL
,	NULL
FBM2-4	NULL
,	NULL
and	NULL
IM9	NULL
.	NULL

Other	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
the	NULL
Burkitt	NULL
's	NULL
lymphomas	NULL
(	NULL
Daudi	NULL
,	NULL
BJAB	NULL
,	NULL
and	NULL
Ramos	NULL
)	NULL
,	NULL
the	NULL
pre-B	NULL
cell	NULL
lines	NULL
(	NULL
REH	NULL
,	NULL
NALM-6	NULL
,	NULL
and	NULL
BLIN1	NULL
)	NULL
,	NULL
the	NULL
sIgM	NULL
*	NULL
early	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
BLIN1	NULL
and	NULL
1E8	NULL
)	NULL
,	NULL
and	NULL
the	NULL
myeloma	NULL
cell	NULL
line	NULL
RPMI8226	NULL
,	NULL
did	NULL
not	NULL
express	NULL
any	NULL
GrpL	NULL
transcripts	NULL
.	NULL

Results	NULL
from	NULL
the	NULL
above	NULL
experiments	NULL
show	NULL
that	NULL
GrpL	NULL
expression	NULL
is	NULL
highly	NULL
regulated	NULL
and	NULL
restricted	NULL
to	NULL
subsets	NULL
within	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

GmpL	NULL
A	NULL
ssodates	NULL
with	NULL
SLP-76	NULL
in	NULL
T	NULL
Cells	NULL
To	NULL
characterize	NULL
the	NULL
GrpL	NULL
protein	NULL
and	NULL
the	NULL
proteins	NULL
with	NULL
which	NULL
it	NULL
interacts	NULL
,	NULL
6	NULL
S158	NULL
145	NULL
277	NULL
330	NULL
SH2	NULL
Pro-rich	NULL
SH3C	NULL
hGrpL	NULL
mGrpL	NULL
hGrpL	NULL
mGrpL	NULL
hGrpL	NULL
mGrpL	NULL
hGrpt	NULL
,	NULL
mGrpL	NULL
hGrpL	NULL
mGrpL	NULL
hGrpL	NULL
mGrpL	NULL
hGrpL	NULL
mGrpL	NULL
B	NULL
hGrpL	NULL
mGrpL	NULL
.	NULL

hGrb2	NULL
hGrap	NULL
m	NULL
>	NULL
o	NULL
o	NULL
hGroL	NULL
p	NULL
E	NULL
G	NULL
mGrpL	NULL
P	NULL
E	NULL
G	NULL
hGrb2	NULL
H	NULL
G	NULL
K	NULL
hGrap	NULL
H	NULL
G	NULL
R	NULL
hGrpL	NULL
-	NULL
98	NULL
h	NULL
N	NULL
K	NULL
mGrpL	NULL
-	NULL
98	NULL
H	NULL
T	NULL
K	NULL
hGrb2	NULL
101	NULL
F	NULL
(	NULL
G	NULL
A	NULL
hGrap	NULL
101	NULL
-v	NULL
A	NULL
S	NULL
[	NULL
6	NULL
hGrpL	NULL
-	NULL
148	NULL
R	NULL
D	NULL
R	NULL
mGroL	NULL
=	NULL
148	NULL
G	NULL
D	NULL
R	NULL
hGrb2	NULL
181	NULL
1	NULL
RJQ	NULL
]	NULL
-	NULL
s	NULL
n	NULL
s	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
>	NULL
-	NULL
161	NULL
H	NULL
B	NULL
Pos	NULL
c	NULL
c	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
e	NULL
e	NULL
n	NULL
e	NULL
e	NULL
n	NULL
n	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
>	NULL
hGpL	NULL
198	NULL
H	NULL
Q	NULL
II	NULL
Q	NULL
P	NULL
Q	NULL
P	NULL
P	NULL
Q	NULL
Y	NULL
A	NULL
PA	NULL
P	NULL
Q	NULL
Q	NULL
L	NULL
mGipL	NULL
197	NULL
HU	NULL
P	NULL
Il	NULL
Q	NULL
Q	NULL
PS	NULL
PQ	NULL
POT	NULL
PG	NULL
P	NULL
Q	NULL
PoP	NULL
e	NULL
ae	NULL
O	NULL
8	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
n	NULL
e	NULL
>	NULL
e	NULL
eae	NULL
c	NULL
n	NULL
n	NULL
n	NULL
s	NULL
n	NULL
n	NULL
n	NULL
<	NULL
e	NULL
e	NULL
e	NULL
e	NULL
>	NULL
hGroL	NULL
mGrpL	NULL
hGrb2	NULL
hGrap	NULL
hGror	NULL
.	NULL

-	NULL
298	NULL
mGrpL	NULL
.	NULL

-	NULL
290	NULL
hGrb2	NULL
189	NULL
hGrap	NULL
-	NULL
185	NULL
®	NULL
a	NULL
3	NULL
4	NULL
we	NULL
generated	NULL
a	NULL
rabbit	NULL
hetero-antiserum	NULL
specific	NULL
for	NULL
GrpL	NULL
by	NULL
immunizing	NULL
with	NULL
a	NULL
His	NULL
Tag	NULL
GrpLSH2	NULL
fusion	NULL
protein	NULL
.	NULL

This	NULL
antiserum	NULL
can	NULL
specifically	NULL
immunoprecipitate	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
two	NULL
proteins	NULL
~38	NULL
and	NULL
40	NULL
kD	NULL
in	NULL
size	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

Both	NULL
proteins	NULL
were	NULL
detectable	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
either	NULL
GrpL	NULL
immunoprecipitates	NULL
(	NULL
IPs	NULL
)	NULL
or	NULL
whole	NULL
cell	NULL
lysates	NULL
.	NULL

This	NULL
antiserum	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
Grb2	NULL
,	NULL
which	NULL
runs	NULL
at	NULL
a	NULL
lower	NULL
molecular	NULL
weight	NULL
on	NULL
gels	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
and	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
and	NULL
by	NULL
all	NULL
criteria	NULL
it	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
GrpL	NULL
.	NULL

To	NULL
detect	NULL
proteins	NULL
potentially	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
GrpL	NULL
,	NULL
we	NULL
pharmacologically	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
with	NULL
1246	NULL
a	NULL
O	NULL
o	NULL
&	NULL
Figure	NULL
1	NULL
.	NULL

Structural	NULL
organization	NULL
of	NULL
GrpL	NULL
and	NULL
amino	NULL
acid	NULL
homology	NULL
comparison	NULL
with	NULL
other	NULL
Grb2-like	NULL
proteins	NULL
.	NULL

A	NULL
schematic	NULL
for	NULL
the	NULL
domain	NULL
organization	NULL
of	NULL
GrpL	NULL
is	NULL
depicted	NULL
in	NULL
the	NULL
upper	NULL
part	NULL
of	NULL
A	NULL
.	NULL

Numbers	NULL
on	NULL
top	NULL
mark	NULL
amino	NULL
acid	NULL
residues	NULL
at	NULL
the	NULL
boundaries	NULL
of	NULL
the	NULL
different	NULL
domains	NULL
.	NULL

The	NULL
lower	NULL
part	NULL
of	NULL
A	NULL
shows	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
comparison	NULL
between	NULL
mouse	NULL
and	NULL
human	NULL
GrpL	NULL
and	NULL
B	NULL
shows	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
comparison	NULL
among	NULL
©	NULL
m	NULL
>	NULL
>	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
Dull	NULL
l	NULL
l	NULL
2	NULL
ase	NULL
mGrpL	NULL
,	NULL
hGrpL	NULL
,	NULL
Grb2	NULL
,	NULL
and	NULL
Grap	NULL
.	NULL

Boxed	NULL
residues	NULL
represent	NULL
homolo-gous	NULL
regions	NULL
.	NULL

Amino	NULL
acids	NULL
in	NULL
bold	NULL
and	NULL
shade	NULL
denote	NULL
identical	NULL
residues	NULL
,	NULL
while	NULL
unshaded	NULL
amino	NULL
acids	NULL
denote	NULL
conserved	NULL
substitutions	NULL
.	NULL

The	NULL
nucleotide	NULL
sequences	NULL
for	NULL
hGrpL	NULL
and	NULL
mGrpL	NULL
are	NULL
available	NULL
from	NULL
EMBL	NULL
GenBank/DDBJ	NULL
under	NULL
accession	NULL
numbers	NULL
AF129476	NULL
and	NULL
AF129477	NULL
.	NULL

pervanadate	NULL
,	NULL
immunoprecipitated	NULL
GrpL	NULL
,	NULL
and	NULL
then	NULL
Western	NULL
blotted	NULL
with	NULL
either	NULL
antiphosphotyrosine	NULL
or	NULL
anti-	NULL
sera	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

2-5	NULL
min	NULL
after	NULL
stimulation	NULL
,	NULL
a	NULL
major	NULL
tyrosine	NULL
phosphorylated	NULL
protein	NULL
40	NULL
kD	NULL
in	NULL
size	NULL
and	NULL
a	NULL
minor	NULL
38-kD	NULL
phos	NULL
phoprotein	NULL
were	NULL
detectable	NULL
in	NULL
anti-GrpL	NULL
but	NULL
not	NULL
control	NULL
serum	NULL
IPs	NULL
.	NULL

This	NULL
doublet	NULL
most	NULL
likely	NULL
corresponds	NULL
to	NULL
GrpL	NULL
itself	NULL
,	NULL
which	NULL
migrates	NULL
to	NULL
the	NULL
same	NULL
position	NULL
on	NULL
gels	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
;	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
these	NULL
bands	NULL
represent	NULL
differen-tially	NULL
phosphorylated	NULL
forms	NULL
of	NULL
GrpL	NULL
.	NULL

Compared	NULL
with	NULL
pervanadate	NULL
,	NULL
TCR	NULL
ligation	NULL
induced	NULL
only	NULL
weak	NULL
tyrosine	NULL
phos	NULL
phorylation	NULL
of	NULL
GrpL	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Novel	NULL
Adaptor	NULL
Molecule	NULL
That	NULL
Regulates	NULL
NF-AT	NULL
Activation	NULL
In	NULL
addition	NULL
to	NULL
the	NULL
38-40-kD	NULL
doublet	NULL
,	NULL
a	NULL
second	NULL
major	NULL
tyrosine	NULL
phosphorylated	NULL
protein	NULL
~68-70	NULL
kD	NULL
in	NULL
size	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
the	NULL
GrpL	NULL
IP	NULL
after	NULL
pervanadate	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
substrates	NULL
for	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
in	NULL
this	NULL
size	NULL
range	NULL
include	NULL
SLP-76	NULL
,	NULL
SHP-2	NULL
,	NULL
Syk	NULL
,	NULL
and	NULL
ZAP-70	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
the	NULL
GrpL	NULL
IP	NULL
obtained	NULL
from	NULL
both	NULL
unstimulated	NULL
and	NULL
pervanadate-	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
detected	NULL
SLP-76	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
but	NULL
not	NULL
ZAP-70	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
SLP-76	NULL
associating	NULL
with	NULL
GrpL	NULL
remained	NULL
relatively	NULL
unchanged	NULL
after	NULL
stimulation	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
SLP-76	NULL
molecule	NULL
coimmunoprecipitated	NULL
with	NULL
GrpL	NULL
before	NULL
stimulation	NULL
showed	NULL
an	NULL
almost	NULL
undetectable	NULL
level	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
GrpL	NULL
can	NULL
interact	NULL
with	NULL
SLP-76	NULL
independently	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
as	NULL
has	NULL
been	NULL
suggested	NULL
for	NULL
Grb2	NULL
and	NULL
SLP-76	NULL
(	NULL
21	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
increased	NULL
signal	NULL
of	NULL
the	NULL
68-70-kD	NULL
molecule	NULL
coimmunoprecipitated	NULL
with	NULL
GrpL	NULL
after	NULL
stimulation	NULL
may	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SLP-76	NULL
and/	NULL
or	NULL
the	NULL
recruitment	NULL
of	NULL
additional	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
of	NULL
the	NULL
same	NULL
size	NULL
to	NULL
GrpL	NULL
.	NULL

In	NULL
the	NULL
SLP-76	NULL
IP	NULL
obtained	NULL
from	NULL
pervanadate-stimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
could	NULL
also	NULL
detect	NULL
tyrosine-phosphorylated	NULL
protein	NULL
at	NULL
38-40	NULL
,	NULL
50-55	NULL
,	NULL
and	NULL
110	NULL
kD	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
.	NULL

GL	NULL
and	NULL
G2	NULL
Interac	NULL
with	NULL
Different	NULL
Molecules	NULL
:	NULL
To	NULL
examine	NULL
the	NULL
possibility	NULL
of	NULL
distinct	NULL
functional	NULL
roles	NULL
played	NULL
by	NULL
different	NULL
Grb2-like	NULL
molecules	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
GrpL	NULL
and	NULL
Grb2	NULL
interact	NULL
with	NULL
different	NULL
proteins	NULL
.	NULL

We	NULL
immunoprecipitated	NULL
either	NULL
GrpL	NULL
or	NULL
Grb2	NULL
from	NULL
Jurkat	NULL
cells	NULL
and	NULL
probed	NULL
for	NULL
associating	NULL
proteins	NULL
.	NULL

SLP-76	NULL
was	NULL
detected	NULL
in	NULL
GrpL	NULL
IPs	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
,	NULL
as	NULL
also	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
C.	NULL
However	NULL
,	NULL
A	NULL
F	NULL
[	NULL
=	NULL
]	NULL
©	NULL
a	NULL
u	NULL
E	NULL
:	NULL
E6	NULL
§	NULL
§	NULL
p	NULL
a	NULL
F	NULL
£08	NULL
3	NULL
5	NULL
Fak	NULL
l	NULL
5	NULL
o	NULL
85	NULL
&	NULL
g	NULL
t	NULL
#	NULL
05	NULL
0	NULL
}	NULL
§	NULL
5	NULL
0	NULL
E	NULL
8	NULL
a	NULL
F	NULL
8	NULL
co	NULL
s	NULL
G08	NULL
49	NULL
¢	NULL
-	NULL
op	NULL
os	NULL
#	NULL
0	NULL
2	NULL
5	NULL
805	NULL
§	NULL
oR	NULL
S	NULL
fP	NULL
f	NULL
£4	NULL
5	NULL
%	NULL
G	NULL
£0	NULL
g	NULL
E	NULL
©	NULL
c	NULL
P	NULL
§	NULL
f	NULL
&	NULL
E.	NULL
;	NULL
ao	NULL
9	NULL
©	NULL
r	NULL
s	NULL
2	NULL
s	NULL
§	NULL
f	NULL
&	NULL
&	NULL
f	NULL
&	NULL
£38	NULL
&	NULL
&	NULL
$	NULL
P	NULL
f	NULL
®	NULL
kb	NULL
O	NULL
<	NULL
RoI	NULL
&	NULL
i	NULL
&	NULL
14	NULL
O	NULL
a	NULL
O	NULL
i-	NULL
&	NULL
i-	NULL
w	NULL
4	NULL
.	NULL

4-1.35-	NULL
&	NULL
wb	NULL
b	NULL
#	NULL
pactin	NULL
m	NULL
w	NULL
C	NULL
Tt	NULL
¢	NULL
53	NULL
8	NULL
w	NULL
8	NULL
o	NULL
©	NULL
1	NULL
M	NULL
is	NULL
33	NULL
~	NULL
>	NULL
v-	NULL
W	NULL
3	NULL
53	NULL
m	NULL
Ao	NULL
C	NULL
m	NULL
-	NULL
0	NULL
2	NULL
Y	NULL
T	NULL
T	NULL
3	NULL
GrpL	NULL
1247	NULL
Law	NULL
et	NULL
al	NULL
.	NULL

Table	NULL
I	NULL
_	NULL
Amino	NULL
A	NULL
dd	NULL
Sequence	NULL
Comparison	NULL
among	NULL
hGpL	NULL
,	NULL
mG	NULL
pL	NULL
,	NULL
G2	NULL
,	NULL
and	NULL
Grp	NULL
Proline-rich	NULL
SH3N	NULL
SH2	NULL
interdomain	NULL
SH3C	NULL
hGrpL/	NULL
mGrpL	NULL
91	NULL
93	NULL
74	NULL
94	NULL
hGrpL/	NULL
Grb2	NULL
52	NULL
56	NULL
<	NULL
5	NULL
50	NULL
hGrpL/	NULL
Grap	NULL
50	NULL
56	NULL
<	NULL
5	NULL
38	NULL
Numbers	NULL
represent	NULL
the	NULL
percentage	NULL
of	NULL
identity	NULL
between	NULL
the	NULL
different	NULL
domains	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
listed	NULL
on	NULL
the	NULL
lefthand	NULL
column	NULL
.	NULL

we	NULL
could	NULL
not	NULL
detect	NULL
any	NULL
SLP-76	NULL
associating	NULL
with	NULL
Grb2	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
was	NULL
the	NULL
presence	NULL
of	NULL
GrpL	NULL
but	NULL
not	NULL
Grb2	NULL
in	NULL
the	NULL
SLP-76	NULL
IPs	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
detect	NULL
Sosl	NULL
and	NULL
Sos2	NULL
,	NULL
GEFs	NULL
of	NULL
Ras	NULL
,	NULL
in	NULL
Grb2	NULL
IPs	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
,	NULL
as	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
other	NULL
cell	NULL
systems	NULL
.	NULL

Interestingly	NULL
,	NULL
no	NULL
detectable	NULL
Sosl	NULL
or	NULL
Sos2	NULL
was	NULL
found	NULL
to	NULL
be	NULL
coimmunoprecipitated	NULL
with	NULL
GrpL	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
GrpL	NULL
preferentially	NULL
complexes	NULL
with	NULL
SLP-76	NULL
,	NULL
whereas	NULL
Grb2	NULL
preferentially	NULL
complexes	NULL
with	NULL
Sos	NULL
!	NULL

or	NULL
Sos2	NULL
.	NULL

Since	NULL
both	NULL
Grb2	NULL
(	NULL
10-14	NULL
)	NULL
and	NULL
Grap	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
can	NULL
associate	NULL
with	NULL
tyrosine-phosphorylated	NULL
LAT/pp36/38	NULL
upon	NULL
TCR	NULL
ligation	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
GrpL	NULL
could	NULL
also	NULL
associate	NULL
with	NULL
tyrosine-phosphorylated	NULL
LAT/pp36/	NULL
38	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
anti-CD3	NULL
,	NULL
and	NULL
LAT/pp36/	NULL
38	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
NP-40	NULL
Jurkat	NULL
cell	NULL
lysates	NULL
at	NULL
various	NULL
time	NULL
points	NULL
after	NULL
stimulation	NULL
.	NULL

As	NULL
reported	NULL
before	NULL
(	NULL
24	NULL
)	NULL
,	NULL
tyrosine	NULL
t	NULL
B	NULL
ha	NULL
Loy	NULL
oa	NULL
®	NULL
[	NULL
o	NULL
$	NULL
58	NULL
5bog	NULL
ss	NULL
-1	NULL
®	NULL
I	NULL
s	NULL
T	NULL
o	NULL
f	NULL
§	NULL
Q	NULL
g	NULL
€	NULL
5	NULL
28S	NULL
w	NULL
Wp	NULL
wo	NULL
185	NULL
``	NULL
ak	NULL
Ng	NULL
GrpL	NULL
.	NULL

-g	NULL
s=	NULL
«	NULL
©	NULL
<	NULL
o	NULL
§	NULL
4	NULL
§	NULL
5	NULL
48	NULL
5nd	NULL
I	NULL
1	NULL
2	NULL
2	NULL
m	NULL
3	NULL
E	NULL
2	NULL
_-	NULL
A	NULL
0	NULL
a	NULL
w	NULL
<	NULL
%	NULL
I	NULL
9	NULL
u	NULL
§	NULL
8	NULL
4	NULL
m	NULL
O	NULL
W	NULL
sz	NULL
®	NULL
«	NULL
£	NULL
Z	NULL
m	NULL
m	NULL
-	NULL
Oo	NULL
¢	NULL
Ko-	NULL
I	NULL
0	NULL
w	NULL
i	NULL
~-	NULL
\o	NULL
sey	NULL
u	NULL
uw	NULL
18s	NULL
-e	NULL
R	NULL
_	NULL
we	NULL
tm	NULL
GL	NULL
vest	NULL
Ame	NULL
dX	NULL
-	NULL
>	NULL
-	NULL
gp	NULL
Go	NULL
uvet	NULL
'-	NULL
``	NULL
.	NULL

B-actin	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Expression	NULL
of	NULL
GrpL	NULL
transcripts	NULL
.	NULL

Multiple	NULL
tissue	NULL
blots	NULL
(	NULL
Clontech	NULL
)	NULL
containing	NULL
2	NULL
pug	NULL
per	NULL
lane	NULL
of	NULL
polyA*	NULL
RNA	NULL
(	NULL
A	NULL
)	NULL
or	NULL
blots	NULL
containing	NULL
30	NULL
jug	NULL
per	NULL
lane	NULL
of	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
various	NULL
hematopoictic	NULL
cell	NULL
lines	NULL
(	NULL
B	NULL
)	NULL
were	NULL
probed	NULL
with	NULL
full-length	NULL
GrpL	NULL
.	NULL

Blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
B-actin	NULL
to	NULL
monitor	NULL
RNA	NULL
loading	NULL
.	NULL

(	NULL
C	NULL
)	NULL
RT-PCR	NULL
using	NULL
conditions	NULL
and	NULL
an	NULL
hGrpL	NULL
primer	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
was	NULL
conducted	NULL
on	NULL
a	NULL
subset	NULL
of	NULL
cell	NULL
lines	NULL
in	NULL
B	NULL
and	NULL
additional	NULL
cell	NULL
lines	NULL
to	NULL
confirm	NULL
and	NULL
extend	NULL
results	NULL
obtained	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

A	NULL
primer	NULL
set	NULL
amplifying	NULL
G3DPH	NULL
was	NULL
used	NULL
to	NULL
monitor	NULL
RNA	NULL
loading	NULL
.	NULL

A	NULL
B_	NULL
pervanadate	NULL
C	NULL
Immunoprecipitates	NULL
minutes	NULL
_	NULL
0	NULL
_	NULL
__	NULL
2	NULL
|	NULL
_	NULL
5	NULL
_	NULL
g	NULL
@	NULL
@	NULL
©	NULL
5	NULL
is	NULL
5	NULL
<	NULL
&	NULL
E	NULL
.	NULL

§	NULL
€	NULL
.f	NULL
.f	NULL
€	NULL
a	NULL
3m	NULL
E4	NULL
E	NULL
<	NULL
&	NULL
©	NULL
£	NULL
58	NULL
ToB	NULL
f	NULL
ge	NULL
E	NULL
=	NULL
g	NULL
$	NULL
G	NULL
E	NULL
3	NULL
®	NULL
$	NULL
G	NULL
F	NULL
aG	NULL
t2	NULL
a	NULL
{	NULL
g	NULL
a	NULL
.	NULL

(	NULL
g	NULL
a	NULL
(	NULL
g	NULL
68	NULL
102-	NULL
kum	NULL
*	NULL
>	NULL
ws	NULL
cGrpL	NULL
.	NULL

71	NULL
-	NULL
t	NULL
9	NULL
.	NULL

i	NULL
-	NULL
my	NULL
wo	NULL
.	NULL

aPY	NULL
wow	NULL
#	NULL
g	NULL
«	NULL
«	NULL
«	NULL
»	NULL
--	NULL
-	NULL
40kD	NULL
46	NULL
ms	NULL
ans	NULL
28	NULL
#	NULL
‘	NULL
aGrpL	NULL
.	NULL

goat	NULL
Ig	NULL
Immunoprecipitates	NULL
Figure	NULL
3	NULL
.	NULL

Biochemical	NULL
characterization	NULL
of	NULL
GrpL	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
antiserum	NULL
against	NULL
GrpL	NULL
generated	NULL
by	NULL
immunizing	NULL
rabbits	NULL
with	NULL
the	NULL
GST/GrpLSH2	NULL
fusion	NULL
protein	NULL
or	NULL
preimmune	NULL
serum	NULL
.	NULL

IPs	NULL
were	NULL
resolved	NULL
along	NULL
with	NULL
whole	NULL
cell	NULL
lysate	NULL
on	NULL
reducing	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
same	NULL
anti-GrpL	NULL
serum	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
cither	NULL
2	NULL
or	NULL
5	NULL
min	NULL
with	NULL
pervanadate	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

NP-40	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-GrpL	NULL
or	NULL
preimmune	NULL
serum	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
antiphosphotyrosine	NULL
antibody	NULL
4G10	NULL
(	NULL
«	NULL
PY	NULL
)	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
GrpL	NULL
in	NULL
different	NULL
lanes	NULL
were	NULL
monitored	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-GrpL	NULL
(	NULL
Grp	NULL
)	NULL
.	NULL

The	NULL
open	NULL
arrow	NULL
indicates	NULL
a	NULL
pre	NULL
rabbit	NULL
Ig	NULL
I	NULL
eSLP-76	NULL
aGrpL	NULL
dominant	NULL
tyrosine-phosphorylated	NULL
protein	NULL
coimmunoprecipitating	NULL
with	NULL
GrpL	NULL
,	NULL
and	NULL
the	NULL
closed	NULL
arrow	NULL
indicates	NULL
the	NULL
mobility	NULL
of	NULL
GrpL	NULL
.	NULL

(	NULL
C	NULL
)	NULL
NP-40	NULL
lysates	NULL
prepared	NULL
from	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
pervanadate-stimulated	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-SLP-76	NULL
(	NULL
«	NULL
SLP-76	NULL
)	NULL
,	NULL
anti-	NULL
GrpL	NULL
(	NULL
«	NULL
GrpL	NULL
)	NULL
,	NULL
or	NULL
normal	NULL
goat	NULL
or	NULL
rabbit	NULL
control	NULL
Ig	NULL
.	NULL

IPs	NULL
were	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
either	NULL
antiphosphotyrosine	NULL
or	NULL
anti-SLP-76	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
phosphoproteins	NULL
migrating	NULL
at	NULL
the	NULL
sizes	NULL
of	NULL
SLP-76	NULL
and	NULL
GrpL	NULL
.	NULL

phosphorylation	NULL
of	NULL
LAT/pp36/	NULL
38	NULL
increased	NULL
dramatically	NULL
after	NULL
TCR	NULL
ligation	NULL
,	NULL
and	NULL
started	NULL
to	NULL
decline	NULL
after	NULL
3	NULL
min	NULL
of	NULL
stimulation	NULL
.	NULL

This	NULL
was	NULL
correlated	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
Grb2	NULL
in	NULL
the	NULL
LAT	NULL
/	NULL
pp36/	NULL
38	NULL
IPs	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
although	NULL
the	NULL
levels	NULL
of	NULL
GrpL	NULL
proteins	NULL
in	NULL
NP-40	NULL
Jurkat	NULL
cell	NULL
lysates	NULL
remained	NULL
unchanged	NULL
throughout	NULL
stimulation	NULL
,	NULL
we	NULL
consistently	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
GrpL	NULL
associating	NULL
with	NULL
LAT/pp36/	NULL
38	NULL
in	NULL
these	NULL
lysates	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

GL	NULL
Regulate	NULL
NF-AT	NULL
Adivation	NULL
in	NULL
T	NULL
Cells	NULL
:	NULL
Since	NULL
SLP-76	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
NF-AT	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
20	NULL
,	NULL
39	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
GrpL	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
this	NULL
pathway	NULL
.	NULL

NF-AT	NULL
activation	NULL
was	NULL
monitored	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
NF-	NULL
AT	NULL
luciferase	NULL
reporter	NULL
construct	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

As	NULL
described	NULL
before	NULL
,	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
IP	NULL
r—w	NULL
IP	NULL
ICI	NULL
-	NULL
al	NULL
&	NULL
-o	NULL
w	NULL
woe	NULL
t	NULL
©	NULL
&	NULL
ma	NULL
£5	NULL
2	NULL
2	NULL
3	NULL
8	NULL
B	NULL
‘	NULL
gg	NULL
’	NULL
ba	NULL
£313	NULL
?	NULL

?	NULL

?	NULL

wth	NULL
wes	NULL
Q	NULL
<	NULL
-	NULL
aGrpL	NULL
Fes	NULL
<	NULL
-	NULL
aSos	NULL
1	NULL
t=	NULL
sin	NULL
IP	NULL
©	NULL
IP	NULL
i	NULL
1—01	NULL
!	NULL

go	NULL
_	NULL
g	NULL
§	NULL
g	NULL
$	NULL
s	NULL
a	NULL
&	NULL
8	NULL
$	NULL
P	NULL
8	NULL
8	NULL
o	NULL
8	NULL
8	NULL
8	NULL
$	NULL
*	NULL
is	NULL
dat	NULL
<	NULL
-	NULL
aSLP-76	NULL
__	NULL
<	NULL
-	NULL
aGrpL	NULL
9	NULL
:	NULL
g	NULL
:	NULL
IP	NULL
«	NULL
©	NULL
&	NULL
aoc	NULL
&	NULL
o	NULL
e	NULL
2	NULL
a	NULL
o	NULL
0	NULL
0	NULL
o	NULL
s	NULL
<	NULL
s	NULL
s	NULL
“	NULL
1—0	NULL
“	NULL
;	NULL
be	NULL
1248	NULL
by	NULL
cotransfection	NULL
of	NULL
a	NULL
SLP-76	NULL
expression	NULL
vector	NULL
augmented	NULL
the	NULL
anti-CD3-induced	NULL
NF-	NULL
AT	NULL
activation	NULL
(	NULL
18	NULL
,	NULL
20	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
GrpL	NULL
alone	NULL
consistently	NULL
augmented	NULL
anti-CD3-induced	NULL
NF-AT	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
an	NULL
additive	NULL
effect	NULL
between	NULL
GrpL	NULL
and	NULL
SLP-76	NULL
on	NULL
NF-AT	NULL
activation	NULL
was	NULL
observed	NULL
when	NULL
both	NULL
were	NULL
overexpressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
SH2	NULL
Domain	NULL
of	NULL
GpL	NULL
Recognizes	NULL
Tyrosine	NULL
phosphorylated	NULL
Protein	NULL
Tyrosine	NULL
Phosphatase	NULL
SHP-2	NULL
In	NULL
Vitro	NULL
.	NULL

-	NULL
Since	NULL
various	NULL
SH2	NULL
domains	NULL
can	NULL
interact	NULL
with	NULL
a	NULL
wide	NULL
spectrum	NULL
of	NULL
tyrosine-phosphorylated	NULL
targets	NULL
,	NULL
we	NULL
tested	NULL
to	NULL
which	NULL
tyrosine-phosphorylated	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
GrpL	NULL
could	NULL
bind	NULL
.	NULL

When	NULL
the	NULL
GST/	NULL
GrpLSH2	NULL
fusion	NULL
protein	NULL
was	NULL
used	NULL
to	NULL
probe	NULL
pervanadate-	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
that	NULL
migrated	NULL
at	NULL
36	NULL
,	NULL
69	NULL
,	NULL
and	NULL
71	NULL
kD	NULL
IP	NULL
CCC	NULL
-	NULL
al	NULL
g	NULL
8	NULL
3	NULL
s	NULL
2	NULL
8	NULL
$	NULL
G	NULL
¢	NULL
*=	NULL
®	NULL
~-	NULL
©S0520000	NULL
4	NULL
.	NULL

GrpL	NULL
and	NULL
Grb	NULL
?	NULL

2	NULL
interact	NULL
with	NULL
different	NULL
effector	NULL
molecules	NULL
.	NULL

(	NULL
A	NULL
)	NULL
NP-40	NULL
ip	NULL
lysates	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
were	NULL
-z	NULL
immunoprecipitated	NULL
-	NULL
with	NULL
-	NULL
anti-SLP-76	NULL
a	NULL
8	NULL
s	NULL
g	NULL
(	NULL
@	NULL
SLP-76	NULL
)	NULL
,	NULL
anti-GrpL	NULL
(	NULL
cGrpL	NULL
)	NULL
,	NULL
anti-Grb2	NULL
o	NULL
$	NULL
$	NULL
4	NULL
¢	NULL
(	NULL
eGrb2	NULL
)	NULL
,	NULL
normal	NULL
goat	NULL
Ig	NULL
(	NULL
glg	NULL
)	NULL
,	NULL
or	NULL
normal	NULL
,	NULL
rabbit	NULL
Ig	NULL
(	NULL
rIg	NULL
)	NULL
.	NULL

IPs	NULL
were	NULL
resolved	NULL
on	NULL
re-G	NULL
Th	NULL
9:3	NULL
;	NULL
-	NULL
<	NULL
-	NULL
aGrb2	NULL
ducing	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
te	NULL
fake	NULL
with	NULL
antisera	NULL
as	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NP-40	NULL
lysates	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
were	NULL
-	NULL
immunoprecipitated	NULL
with	NULL
anti-SLP-76	NULL
(	NULL
@	NULL
SLP-76	NULL
)	NULL
anti-GrpL	NULL
(	NULL
@	NULL
GrpL	NULL
)	NULL
,	NULL
anti-Sos1	NULL
(	NULL
«	NULL
Sos1	NULL
)	NULL
,	NULL
anti-Sos2	NULL
(	NULL
«	NULL
Sos2	NULL
)	NULL
,	NULL
or	NULL
normal	NULL
rabbit	NULL
Ig	NULL
(	NULL
rIg	NULL
)	NULL
.	NULL

IPs	NULL
were	NULL
resolved	NULL
on	NULL
reducing	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
antisera	NULL
as	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Novel	NULL
Adaptor	NULL
Molecule	NULL
That	NULL
Regulates	NULL
NF-AT	NULL
Activation	NULL
aLAT	NULL
rig	NULL
romancing	NULL
0	NULL
20	NULL
``	NULL
1°	NULL
3°	NULL
10°	NULL
10°	NULL
CD3	NULL
Cross-linking	NULL
000000	NULL
aLAT	NULL
<	NULL
-	NULL
LAT	NULL
we	NULL
we	NULL
we	NULL
as	NULL
#	NULL
4	NULL
w*	NULL
#	NULL
s	NULL
+-	NULL
IgH	NULL
«	NULL
PY	NULL
BH	NULL
a	NULL
-	NULL
-	NULL
-u	NULL
--	NULL
aGrb2	NULL
-	NULL
Figure	NULL
5	NULL
.	NULL

GrpL	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
LAT/pp36/	NULL
38	NULL
.	NULL

NP-40	NULL
Pee	NULL
P	NULL
lysates	NULL
were	NULL
prepared	NULL
from	NULL
anti	NULL
CD3-stimulated	NULL
Jurkat	NULL
cells	NULL
and	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-LAT/pp36/	NULL
38	NULL
.	NULL

Normal	NULL
rabbit	NULL
Ig	NULL
(	NULL
rlg	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
negative	NULL
control	NULL
.	NULL

The	NULL
anti-LAT/	NULL
pp36/38	NULL
IPs	NULL
were	NULL
resolved	NULL
by	NULL
-	NULL
...	NULL
,	NULL
reducing	NULL
SDS-PAGE	NULL
on	NULL
repli-	NULL
cate	NULL
gels	NULL
and	NULL
immunoblotted	NULL
eGRPL	NULL
_	NULL
rig	NULL
with	NULL
anti-LAT/	NULL
pp36/	NULL
38	NULL
(	NULL
eLAT/	NULL
m	NULL
?	NULL

CD3	NULL
Cross-linking	NULL
pp36/	NULL
38	NULL
)	NULL
,	NULL
antlghosphotyroslnc	NULL
(	NULL
4G10	NULL
)	NULL
(	NULL
aPY	NULL
)	NULL
,	NULL
anti-Grb2	NULL
and	NULL
anti-GrpL	NULL
(	NULL
@	NULL
GrpL	NULL
)	NULL
.	NULL

Expres	NULL
+-	NULL
IgH	NULL
sion	NULL
of	NULL
GrpL	NULL
in	NULL
these	NULL
cells	NULL
during	NULL
eGrpL	NULL
stimulation	NULL
were	NULL
monitored	NULL
by	NULL
®	NULL
m	NULL
ae	NULL
ue	NULL
ue	NULL
VM	NULL
.-	NULL
Coll	NULL
immunoblotting	NULL
the	NULL
anti-GrpL	NULL
IPs	NULL
with	NULL
anti-GrpL	NULL
(	NULL
cGrpL	NULL
)	NULL
.	NULL

could	NULL
be	NULL
readily	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
we	NULL
also	NULL
detected	NULL
95-	NULL
and	NULL
130-kD	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
.	NULL

The	NULL
GST/GrpLSH2	NULL
fusion	NULL
protein	NULL
also	NULL
precipitated	NULL
a	NULL
similar	NULL
pattern	NULL
from	NULL
lysates	NULL
prepared	NULL
from	NULL
anti-CD3-stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
.	NULL

By	NULL
analogy	NULL
to	NULL
Grb2	NULL
(	NULL
24	NULL
)	NULL
,	NULL
these	NULL
proteins	NULL
could	NULL
be	NULL
LAT	NULL
,	NULL
ZAP-70	NULL
,	NULL
SHP-2	NULL
,	NULL
Vav	NULL
,	NULL
and	NULL
perhaps	NULL
c-Cbl	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
confirm	NULL
that	NULL
SHP-2	NULL
was	NULL
among	NULL
the	NULL
phosphoproteins	NULL
precipitated	NULL
by	NULL
the	NULL
GST	NULL
/	NULL
GrpLSH2	NULL
fusion	NULL
protein	NULL
from	NULL
pervan-adate-activated	NULL
Jurkat	NULL
cells	NULL
Although	NULL
tyrosine-phosphorylated	NULL
SLP-76	NULL
also	NULL
migrates	NULL
at	NULL
~70	NULL
kD	NULL
,	NULL
we	NULL
consistently	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
SLP-76	NULL
precipitated	NULL
by	NULL
GST	NULL
/	NULL
GrpSH2	NULL
.	NULL

Discussion	NULL
Critical	NULL
functions	NULL
are	NULL
played	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
adaptor	NULL
molecules	NULL
in	NULL
linking	NULL
receptor	NULL
proximal	NULL
signal	NULL
transduction	NULL
events	NULL
such	NULL
as	NULL
activation	NULL
of	NULL
receptor-associated	NULL
kinases	NULL
to	NULL
downstream	NULL
effector	NULL
molecules	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
Grb	NULL
family	NULL
of	NULL
adaptor	NULL
proteins	NULL
.	NULL

GrpL	NULL
shares	NULL
similar	NULL
structural	NULL
organization	NULL
as	NULL
Grb2	NULL
and	NULL
Grap	NULL
.	NULL

A	NULL
distinguishing	NULL
feature	NULL
of	NULL
GrpL	NULL
not	NULL
found	NULL
in	NULL
Grb2	NULL
or	NULL
Grap	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-amino	NULL
acid	NULL
stretch	NULL
connecting	NULL
its	NULL
SH2	NULL
and	NULL
SH3C	NULL
domains	NULL
.	NULL

Although	NULL
this	NULL
region	NULL
is	NULL
the	NULL
least	NULL
conserved	NULL
be	NULL
1249	NULL
Law	NULL
et	NULL
al	NULL
.	NULL

100	NULL
90	NULL
80	NULL
70	NULL
60	NULL
4	NULL
50	NULL
40	NULL
%	NULL
of	NULL
PMA/Ionomycin	NULL
30	NULL
20	NULL
10	NULL
4	NULL
20	NULL
ug	NULL
pEF	NULL
20	NULL
ug	NULL
pEFGrpL	NULL
20	NULL
ug	NULL
pEF-SLP-76	NULL
20	NULL
ug	NULL
pEF-SLP-76	NULL
+	NULL
SLP-76	NULL
+	NULL
20	NULL
ug	NULL
pEF-	NULL
-	NULL
10	NULL
ug	NULL
pBF-GipL	NULL
GrpL	NULL
10	NULL
ug	NULL
pEF	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
GrpL	NULL
regulates	NULL
NF-AT	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
in	NULL
triplicate	NULL
with	NULL
20	NULL
jg	NULL
of	NULL
the	NULL
NF-AT	NULL
Luc	NULL
and	NULL
empty	NULL
vector	NULL
(	NULL
pEF	NULL
)	NULL
,	NULL
pEF-GrpL	NULL
,	NULL
pEF-SLP-76	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
pEF-GrpL	NULL
and	NULL
pEF-SLP-76	NULL
at	NULL
concentrations	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
anti-TCR	NULL
C305	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
or	NULL
left	NULL
unstimulated	NULL
in	NULL
medium	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
then	NULL
determined	NULL
on	NULL
each	NULL
transfected	NULL
cell	NULL
population	NULL
.	NULL

The	NULL
maximal	NULL
NF-AT	NULL
responses	NULL
for	NULL
the	NULL
various	NULL
transfection	NULL
conditions	NULL
were	NULL
determined	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
,	NULL
and	NULL
did	NULL
not	NULL
differ	NULL
significantly	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
overexpressing	NULL
GrpL	NULL
and/or	NULL
SLP-76	NULL
are	NULL
shown	NULL
as	NULL
percentage	NULL
of	NULL
the	NULL
maximal	NULL
NF-AT	NULL
responses	NULL
for	NULL
each	NULL
transfection	NULL
conditions	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

tween	NULL
mGrpL	NULL
and	NULL
hGrpL	NULL
,	NULL
it	NULL
does	NULL
contain	NULL
multiple	NULL
proline	NULL
and	NULL
glutamine	NULL
residues	NULL
at	NULL
conserved	NULL
positions	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
two	NULL
PxxP	NULL
motifs	NULL
are	NULL
found	NULL
in	NULL
both	NULL
hGrpL	NULL
and	NULL
mGrpL	NULL
.	NULL

In	NULL
hGrpL	NULL
,	NULL
they	NULL
are	NULL
P191TLP	NULL
and	NULL
P202QPP	NULL
;	NULL
in	NULL
mGrpL	NULL
,	NULL
they	NULL
are	NULL
P190LGP	NULL
and	NULL
P210QPP	NULL
.	NULL

These	NULL
poly-proline	NULL
motifs	NULL
conform	NULL
to	NULL
the	NULL
consensus	NULL
sequence	NULL
recognized	NULL
by	NULL
different	NULL
SH3	NULL
domains	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
proline	NULL
residues	NULL
in	NULL
GrpL	NULL
do	NULL
constitute	NULL
a	NULL
proline-rich	NULL
domain	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
as	NULL
yet	NULL
to	NULL
be	NULL
defined	NULL
SH3-containing	NULL
proteins	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
broadly	NULL
expression	NULL
Grb2	NULL
,	NULL
GrpL	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
hematopoietic	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
this	NULL
re-gard	NULL
,	NULL
GrpL	NULL
is	NULL
similar	NULL
to	NULL
Grap	NULL
that	NULL
transcripts	NULL
for	NULL
both	NULL
are	NULL
found	NULL
at	NULL
much	NULL
higher	NULL
levels	NULL
in	NULL
hematopoietic	NULL
tissues	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Although	NULL
Grap	NULL
is	NULL
preferentially	NULL
expressed	NULL
in	NULL
blood	NULL
cells	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
its	NULL
expression	NULL
in	NULL
different	NULL
stages	NULL
of	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
maturation	NULL
or	NULL
in	NULL
different	NULL
lymphocyte	NULL
sub-sets	NULL
.	NULL

GrpL	NULL
transcripts	NULL
are	NULL
expressed	NULL
at	NULL
lower	NULL
levels	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
than	NULL
in	NULL
the	NULL
secondary	NULL
lymphoid	NULL
organs	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
highest	NULL
levels	NULL
of	NULL
GrpL	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
thymus	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
GrpL	NULL
may	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
regulating	NULL
early	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
on	NULL
cell	NULL
lines	NULL
also	NULL
demonstrates	NULL
that	NULL
GrpL	NULL
transcripts	NULL
are	NULL
not	NULL
expressed	NULL
in	NULL
all	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
their	NULL
expression	NULL
may	NULL
be	NULL
modu-	NULL
@	NULL
A	NULL
3	NULL
B	NULL
©	NULL
8s	NULL
one	NULL
i	NULL
5	NULL
€t	NULL
5	NULL
is	NULL
2	NULL
3	NULL
8	NULL
3	NULL
E	NULL
a	NULL
IP	NULL
ad	NULL
ou	NULL
w	NULL
``	NULL
~-	NULL
a	NULL
'	NULL
ps	NULL
I	NULL
T.	NULL
T	NULL
t	NULL
®	NULL
&	NULL
&	NULL
=d	NULL
-1	NULL
-	NULL
!	NULL

«	NULL
4	NULL
g	NULL
%	NULL
&	NULL
6	NULL
O	NULL
O	NULL
O	NULL
5	NULL
hobo	NULL
Eo	NULL
ok	NULL
-	NULL
oF	NULL
m	NULL
m	NULL
a	NULL
u	NULL
u	NULL
a	NULL
m	NULL
0	NULL
0G	NULL
G	NULL
0G	NULL
0	NULL
0G	NULL
0	NULL
G	NULL
G	NULL
-200	NULL
-	NULL
200	NULL
-97	NULL
-	NULL
97	NULL
aSHP2-	NULL
»	NULL
-	NULL
©	NULL
_	NULL
gg	NULL
-	NULL
43	NULL
-43	NULL
-	NULL
29	NULL
-29	NULL
k	NULL
WE	NULL
4	NULL
®	NULL
#	NULL
H4	NULL
wop	NULL
)	NULL
|	NULL
csr	NULL
s-|	NULL
Figure	NULL
7	NULL
.	NULL

-	NULL
The	NULL
SH2	NULL
domain	NULL
of	NULL
GrpL	NULL
interacts	NULL
with	NULL
SHP-2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
g/	NULL
ml	NULL
of	NULL
anti-CD3	NULL
(	NULL
«	NULL
CD3	NULL
)	NULL
or	NULL
pervanadate	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Control	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
cither	NULL
isotype-matched	NULL
control	NULL
IgG	NULL
or	NULL
medium	NULL
alone	NULL
.	NULL

NP-40	NULL
lysates	NULL
were	NULL
precipitated	NULL
with	NULL
cither	NULL
GST	NULL
or	NULL
GST/	NULL
GrpLSH2	NULL
,	NULL
resolved	NULL
on	NULL
reducing	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
antiphosphotyrosine	NULL
antibody	NULL
4G10	NULL
.	NULL

Arrows	NULL
indicates	NULL
major	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
detected	NULL
in	NULL
the	NULL
GST	NULL
/	NULL
GrpLSH2	NULL
precipitates	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Replicate	NULL
precipitates	NULL
obtained	NULL
from	NULL
pervanadate-stimulated	NULL
Jurkat	NULL
cells	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-SLP-76	NULL
.	NULL

lated	NULL
during	NULL
lymphocyte	NULL
ontogeny	NULL
by	NULL
specific	NULL
signals	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
fractionated	NULL
normal	NULL
B	NULL
cells	NULL
into	NULL
subsets	NULL
and	NULL
measured	NULL
levels	NULL
of	NULL
GrpL	NULL
transcripts	NULL
.	NULL

A	NULL
clear	NULL
difference	NULL
was	NULL
observed	NULL
in	NULL
GrpL	NULL
transcript	NULL
expression	NULL
in	NULL
naive	NULL
but	NULL
not	NULL
in	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
(	NULL
Solow	NULL
,	NULL
S.A.	NULL
,	NULL
A.J	NULL
.	NULL

Marshall	NULL
,	NULL
T	NULL
.J	NULL
.	NULL

Yun	NULL
,	NULL
MK	NULL
.	NULL

Ewings	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

Clark	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
signals	NULL
involved	NULL
in	NULL
switching	NULL
the	NULL
expression	NULL
of	NULL
GrpL	NULL
on	NULL
and	NULL
off	NULL
will	NULL
provide	NULL
further	NULL
insights	NULL
into	NULL
the	NULL
functions	NULL
of	NULL
GrpL	NULL
and	NULL
its	NULL
associating	NULL
proteins	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
lymphocyte	NULL
development	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
one	NULL
of	NULL
the	NULL
GrpL-	NULL
interacting	NULL
proteins	NULL
to	NULL
be	NULL
SLP-76	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Interaction	NULL
between	NULL
GrpL	NULL
and	NULL
SLP-76	NULL
appears	NULL
to	NULL
be	NULL
constitutive	NULL
,	NULL
since	NULL
it	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
both	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
T	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
A	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
this	NULL
interaction	NULL
may	NULL
not	NULL
require	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
either	NULL
SLP-76	NULL
or	NULL
GrpL	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
,	NULL
results	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
show	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
SLP-76	NULL
coimmunoprecipitating	NULL
with	NULL
GrpL	NULL
remained	NULL
relatively	NULL
constant	NULL
,	NULL
although	NULL
SLP-76	NULL
became	NULL
heavily	NULL
tyrosine-phosphorylated	NULL
after	NULL
pervanadate	NULL
treatment	NULL
.	NULL

Hence	NULL
,	NULL
our	NULL
data	NULL
argue	NULL
against	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
GrpL	NULL
mediates	NULL
its	NULL
interaction	NULL
with	NULL
SLP-76	NULL
.	NULL

Grb2	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
an	NULL
adaptor	NULL
molecule	NULL
capable	NULL
of	NULL
associating	NULL
with	NULL
SLP-76	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
GST	NULL
fusion	NULL
proteins	NULL
containing	NULL
Grb2	NULL
or	NULL
Grb2	NULL
SH3	NULL
domains	NULL
recognized	NULL
SLP-76	NULL
from	NULL
lysates	NULL
of	NULL
resting	NULL
or	NULL
activated	NULL
T	NULL
cells	NULL
independent	NULL
of	NULL
its	NULL
tyrosine-phosphorylation	NULL
(	NULL
21	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Using	NULL
1250	NULL
deletional	NULL
mutants	NULL
of	NULL
SLP-76	NULL
,	NULL
the	NULL
Grb2	NULL
binding	NULL
site	NULL
was	NULL
subsequently	NULL
mapped	NULL
to	NULL
the	NULL
central	NULL
proline-rich	NULL
region	NULL
of	NULL
SLP-76	NULL
from	NULL
amino	NULL
acid	NULL
residues	NULL
224-244	NULL
(	NULL
21	NULL
)	NULL
.	NULL

These	NULL
results	NULL
implicate	NULL
the	NULL
SH3	NULL
domain	NULL
of	NULL
Grb2	NULL
to	NULL
be	NULL
the	NULL
primary	NULL
mediator	NULL
for	NULL
interaction	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
similar	NULL
structure	NULL
between	NULL
GrpL	NULL
and	NULL
Grb2	NULL
and	NULL
the	NULL
phosphorylation-indepen-dent	NULL
interaction	NULL
between	NULL
GrpL	NULL
and	NULL
SLP-76	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
SH3	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
of	NULL
GrpL	NULL
also	NULL
mediates	NULL
its	NULL
interaction	NULL
with	NULL
SLP-76	NULL
.	NULL

Experiments	NULL
are	NULL
currently	NULL
in	NULL
progress	NULL
to	NULL
examine	NULL
this	NULL
possibility	NULL
.	NULL

Several	NULL
recent	NULL
studies	NULL
have	NULL
provided	NULL
strong	NULL
evidence	NULL
for	NULL
an	NULL
essential	NULL
function	NULL
served	NULL
by	NULL
SLP-76	NULL
in	NULL
T	NULL
lineage	NULL
cells	NULL
.	NULL

Biochemical	NULL
experiments	NULL
show	NULL
that	NULL
SLP-76	NULL
can	NULL
interact	NULL
with	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
regulators	NULL
.	NULL

TCR	NULL
ligation	NULL
induces	NULL
ZAP-70	NULL
to	NULL
phosphorylate	NULL
SLP-76	NULL
at	NULL
three	NULL
NH	NULL
,	NULL
-terminal	NULL
tyrosine	NULL
residues	NULL
(	NULL
20	NULL
,	NULL
30	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Once	NULL
phosphorylated	NULL
on	NULL
its	NULL
NH	NULL
,	NULL
-terminal	NULL
tyrosine	NULL
residues	NULL
,	NULL
in	NULL
particular	NULL
Y113	NULL
and	NULL
Y128	NULL
,	NULL
SLP-76	NULL
can	NULL
be	NULL
bound	NULL
by	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Vav	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
SLP-76	NULL
augment	NULL
IL-2	NULL
promoter	NULL
activity	NULL
(	NULL
21	NULL
)	NULL
,	NULL
and	NULL
SLP-76	NULL
also	NULL
acts	NULL
synergistically	NULL
with	NULL
Vav	NULL
to	NULL
augment	NULL
IL-2	NULL
promoter	NULL
activity	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
SLP-76	NULL
is	NULL
absolutely	NULL
dependent	NULL
on	NULL
an	NULL
intact	NULL
proline-rich	NULL
region	NULL
,	NULL
and	NULL
hence	NULL
,	NULL
an	NULL
interaction	NULL
with	NULL
adaptor	NULL
proteins	NULL
containing	NULL
SH3	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
(	NULL
21	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
COOH-terminal	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
binds	NULL
to	NULL
a	NULL
130-kD	NULL
tyrosine-phosphorylated	NULL
protein	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
has	NULL
been	NULL
cloned	NULL
,	NULL
designated	NULL
to	NULL
be	NULL
SLAP-130/Fyb	NULL
,	NULL
and	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
downregulating	NULL
the	NULL
activating	NULL
function	NULL
of	NULL
SLP-76	NULL
on	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
most	NULL
compelling	NULL
evidence	NULL
to	NULL
argue	NULL
for	NULL
an	NULL
indispensable	NULL
in	NULL
vivo	NULL
function	NULL
of	NULL
SLP-76	NULL
in	NULL
T	NULL
lineage	NULL
cell	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
recent	NULL
gene	NULL
targeting	NULL
experiments	NULL
.	NULL

SLP-76	NULL
~	NULL
mice	NULL
are	NULL
characterized	NULL
by	NULL
an	NULL
early	NULL
arrest	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

CD4	NULL
,	NULL
and	NULL
CD8+	NULL
thymocyte	NULL
populations	NULL
are	NULL
completely	NULL
absent	NULL
from	NULL
thymuses	NULL
of	NULL
SLP-76	NULL
knockout	NULL
mice	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
corresponding	NULL
lack	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
the	NULL
SLP-76-~-	NULL
mice	NULL
,	NULL
TCR	NULL
-B	NULL
chain	NULL
genes	NULL
appear	NULL
to	NULL
undergo	NULL
normal	NULL
rearrangement	NULL
and	NULL
exogenous	NULL
anti-CD3	NULL
fails	NULL
to	NULL
drive	NULL
the	NULL
generation	NULL
of	NULL
double	NULL
positive	NULL
cells	NULL
Therefore	NULL
,	NULL
it	NULL
is	NULL
proposed	NULL
that	NULL
the	NULL
absence	NULL
of	NULL
SLP-76	NULL
may	NULL
render	NULL
the	NULL
pre-TCR	NULL
complex	NULL
fail	NULL
to	NULL
deliver	NULL
maturational	NULL
signals	NULL
to	NULL
developing	NULL
T	NULL
cells	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
GrpL	NULL
associates	NULL
with	NULL
SLP-76	NULL
in	NULL
vivo	NULL
suggests	NULL
GrpL	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
TCR	NULL
-mediated	NULL
signal	NULL
transduction	NULL
cascades	NULL
.	NULL

Studies	NULL
from	NULL
different	NULL
laboratories	NULL
have	NULL
convincingly	NULL
demonstrated	NULL
binding	NULL
of	NULL
recombi-nant	NULL
Grb2	NULL
or	NULL
Grb2	NULL
SH3	NULL
domains	NULL
to	NULL
SLP-76	NULL
both	NULL
in	NULL
cell	NULL
lysates	NULL
and	NULL
on	NULL
Western	NULL
blots	NULL
(	NULL
9	NULL
,	NULL
21	NULL
,	NULL
27	NULL
)	NULL
,	NULL
but	NULL
the	NULL
presence	NULL
of	NULL
SLP-76	NULL
in	NULL
Grb2	NULL
IPs	NULL
and	NULL
vice	NULL
versa	NULL
have	NULL
not	NULL
been	NULL
reported	NULL
thus	NULL
far	NULL
.	NULL

O	NULL
ur	NULL
data	NULL
argue	NULL
that	NULL
SLP-76	NULL
is	NULL
more	NULL
likely	NULL
to	NULL
associate	NULL
with	NULL
GrpL	NULL
than	NULL
Grb2	NULL
under	NULL
physiological	NULL
conditions	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
GrpL/	NULL
SLP-76	NULL
association	NULL
may	NULL
regulate	NULL
signaling	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
involving	NULL
SLP-76	NULL
in	NULL
T	NULL
cells	NULL
One	NULL
downstream	NULL
target	NULL
for	NULL
SLP-76	NULL
is	NULL
NF-AT	NULL
.	NULL

SLP-76	NULL
and	NULL
Vav	NULL
can	NULL
synergistically	NULL
enhance	NULL
anti-CD3-induced	NULL
NF-AT	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Results	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
demonstrate	NULL
that	NULL
overexpression	NULL
of	NULL
GrpL	NULL
alone	NULL
is	NULL
sufficient	NULL
to	NULL
enhance	NULL
the	NULL
Novel	NULL
Adaptor	NULL
Molecule	NULL
That	NULL
Regulates	NULL
NF-AT	NULL
Activation	NULL
TCR	NULL
-induced	NULL
NF-AT	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
GrpL	NULL
cooperated	NULL
with	NULL
SLP-76	NULL
in	NULL
this	NULL
pathway	NULL
as	NULL
suggested	NULL
by	NULL
the	NULL
additive	NULL
effect	NULL
upon	NULL
overexpression	NULL
of	NULL
both	NULL
GrpL	NULL
and	NULL
SLP-76	NULL
.	NULL

Given	NULL
the	NULL
functions	NULL
of	NULL
SLP-76	NULL
in	NULL
regulating	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
gene	NULL
expression	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
the	NULL
GEF	NULL
Vav	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
GrpL	NULL
may	NULL
also	NULL
modulate	NULL
the	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
activity	NULL
of	NULL
Vav	NULL
via	NULL
its	NULL
association	NULL
with	NULL
SLP-76	NULL
to	NULL
regulate	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
func-tions	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
Grb2	NULL
may	NULL
function	NULL
principally	NULL
via	NULL
the	NULL
Sos1	NULL
and	NULL
Sos2	NULL
GEFs	NULL
.	NULL

Another	NULL
feature	NULL
that	NULL
further	NULL
distinguishes	NULL
GrpL	NULL
from	NULL
Grb2	NULL
is	NULL
the	NULL
lack	NULL
of	NULL
association	NULL
between	NULL
GrpL	NULL
and	NULL
tyrosine-phosphorylated	NULL
LAT/pp36/	NULL
38	NULL
in	NULL
NP-40	NULL
lysates	NULL
prepared	NULL
from	NULL
TCR	NULL
-activated	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Detergent-insoluble	NULL
membrane	NULL
subdomains	NULL
known	NULL
as	NULL
glycolipid-enriched	NULL
mi-crodomains	NULL
or	NULL
detergent-insoluble	NULL
rafts	NULL
concentrated	NULL
with	NULL
lipid-linked	NULL
signaling	NULL
proteins	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
focal	NULL
areas	NULL
from	NULL
which	NULL
receptor-mediated	NULL
signaling	NULL
originates	NULL
(	NULL
42-44	NULL
)	NULL
.	NULL

R	NULL
ecently	NULL
,	NULL
components	NULL
of	NULL
the	NULL
activation	NULL
TCR	NULL
complex	NULL
,	NULL
including	NULL
tyrosine-phosphorylated	NULL
LAT	NULL
,	NULL
have	NULL
been	NULL
localized	NULL
to	NULL
such	NULL
detergent-insoluble	NULL
rafts	NULL
,	NULL
and	NULL
disruption	NULL
of	NULL
these	NULL
rafts	NULL
inhibits	NULL
signaling	NULL
via	NULL
the	NULL
TCR	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Since	NULL
GrpL	NULL
appears	NULL
to	NULL
be	NULL
an	NULL
integral	NULL
part	NULL
of	NULL
the	NULL
TCR	NULL
-mediated	NULL
NF-AT	NULL
activation	NULL
pathway	NULL
(	NULL
Figs	NULL
.	NULL

4-6	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
GrpL	NULL
may	NULL
also	NULL
be	NULL
localized	NULL
to	NULL
rafts	NULL
upon	NULL
TCR	NULL
liga-tion	NULL
.	NULL

This	NULL
may	NULL
allow	NULL
GrpL	NULL
to	NULL
interact	NULL
with	NULL
upstream	NULL
molecules	NULL
activated	NULL
by	NULL
the	NULL
TCR	NULL
,	NULL
including	NULL
tyrosine-phosphorylated	NULL
LAT	NULL
in	NULL
rafts	NULL
Experiments	NULL
are	NULL
now	NULL
in	NULL
progress	NULL
to	NULL
examine	NULL
this	NULL
possibility	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
binding	NULL
of	NULL
GrpLSH2	NULL
domain	NULL
to	NULL
tyrosine-phosphorylated	NULL
SHP-2	NULL
suggests	NULL
that	NULL
SHP-2	NULL
may	NULL
potentially	NULL
interact	NULL
with	NULL
GrpL	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
not	NULL
yet	NULL
detected	NULL
an	NULL
in	NULL
vivo	NULL
association	NULL
between	NULL
GrpL	NULL
and	NULL
SHP-2	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

SHP-2	NULL
possesses	NULL
the	NULL
dual	NULL
functions	NULL
of	NULL
either	NULL
potentiating	NULL
or	NULL
inhibiting	NULL
signal	NULL
transduction	NULL
depending	NULL
on	NULL
the	NULL
receptor	NULL
system	NULL
involved	NULL
.	NULL

For	NULL
example	NULL
,	NULL
SHP-2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
coupling	NULL
receptors	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
MAPK	NULL
pathway	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
SHP-2	NULL
interacts	NULL
with	NULL
CTLA-4	NULL
,	NULL
which	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
the	NULL
mechanism	NULL
whereby	NULL
CTLA-4	NULL
down-regulates	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
possibly	NULL
via	NULL
dephosphorylation	NULL
of	NULL
Shc	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
suggests	NULL
that	NULL
SHP-2	NULL
may	NULL
also	NULL
be	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
multimeric	NULL
complex	NULL
involving	NULL
Grb2	NULL
,	NULL
LAT/	NULL
pp36/	NULL
38	NULL
,	NULL
SHP-2	NULL
,	NULL
and	NULL
a	NULL
110-kD	NULL
tyrosine-phosphorylated	NULL
protein	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
expression	NULL
of	NULL
a	NULL
SHP-2	NULL
mutant	NULL
devoid	NULL
of	NULL
phosphatase	NULL
activity	NULL
inhibits	NULL
the	NULL
TCR	NULL
-induced	NULL
MAPK	NULL
pathway	NULL
activation	NULL
.	NULL

Similar	NULL
to	NULL
Grb2	NULL
,	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
GrpL	NULL
mediates	NULL
binding	NULL
to	NULL
SHP-2	NULL
.	NULL

This	NULL
binding	NULL
is	NULL
dependent	NULL
on	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SHP-2	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
after	NULL
TCR	NULL
ligation	NULL
,	NULL
the	NULL
interaction	NULL
between	NULL
Grb2	NULL
Figure	NULL
8	NULL
.	NULL

A	NULL
model	NULL
for	NULL
how	NULL
GrpL	NULL
may	NULL
function	NULL
in	NULL
TCR-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Results	NULL
from	NULL
our	NULL
study	NULL
demonstrate	NULL
that	NULL
GrpL	NULL
and	NULL
Grb2	NULL
may	NULL
dif	NULL
ferentially	NULL
associate	NULL
with	NULL
SLP-76	NULL
,	NULL
LAT/pp36/	NULL
p38	NULL
,	NULL
and	NULL
Sos1/	NULL
2	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
preferential	NULL
interaction	NULL
between	NULL
GrpL	NULL
and	NULL
SLP-76	NULL
suggests	NULL
that	NULL
GrpL	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
NF-AT	NULL
pathway	NULL
during	NULL
TCR-mediated	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Co	NULL
9	NULL
<	NULL
<	NULL
-	NULL
<	NULL
0	NULL
he	NULL
and	NULL
SHP-2	NULL
may	NULL
facilitate	NULL
the	NULL
redistribution	NULL
of	NULL
the	NULL
GrpL-SLP-76	NULL
complex	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

Consequently	NULL
,	NULL
SLP-76	NULL
would	NULL
become	NULL
available	NULL
for	NULL
phosphorylation	NULL
by	NULL
ZAP-70	NULL
to	NULL
generate	NULL
the	NULL
Vav	NULL
binding	NULL
sites	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
support	NULL
a	NULL
model	NULL
in	NULL
which	NULL
dis	NULL
tinct	NULL
complexes	NULL
of	NULL
Grb2/Sosl/Sos2	NULL
and	NULL
GrpL-SLP-76	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
connecting	NULL
the	NULL
TCR	NULL
to	NULL
the	NULL
Ras	NULL
and	NULL
R	NULL
ho/	NULL
R	NULL
ac/	NULL
CDC42-mediated	NULL
effector	NULL
pathways	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Grb2	NULL
is	NULL
the	NULL
primary	NULL
adaptor	NULL
molecule	NULL
responsible	NULL
for	NULL
the	NULL
recruitment	NULL
of	NULL
the	NULL
GEFs	NULL
Sos1	NULL
and	NULL
Sos2	NULL
for	NULL
Ras	NULL
(	NULL
26	NULL
)	NULL
to	NULL
LAT/pp36/	NULL
38	NULL
.	NULL

The	NULL
lymphoid-restricted	NULL
,	NULL
Grb2-like	NULL
adaptor	NULL
protein	NULL
Grap	NULL
can	NULL
also	NULL
serve	NULL
a	NULL
similar	NULL
function	NULL
by	NULL
interacting	NULL
with	NULL
Sos	NULL
and	NULL
R	NULL
as	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Recruitment	NULL
of	NULL
R	NULL
as	NULL
to	NULL
the	NULL
inner	NULL
plasma	NULL
membrane	NULL
activates	NULL
distal	NULL
MAPKs	NULL
including	NULL
Erk	NULL
]	NULL
and	NULL
Erk2	NULL
(	NULL
26	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
Vav	NULL
,	NULL
a	NULL
GEF	NULL
for	NULL
the	NULL
R	NULL
ho/	NULL
R	NULL
ac/	NULL
CDC42	NULL
family	NULL
of	NULL
GTP-binding	NULL
proteins	NULL
expressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
,	NULL
binds	NULL
to	NULL
tyrosine-phosphorylated	NULL
SLP-76	NULL
via	NULL
its	NULL
SH2	NULL
domain	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
regulates	NULL
NF-	NULL
AT	NULL
activation	NULL
(	NULL
18	NULL
)	NULL
and	NULL
cytoskeletal	NULL
reorganization	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Since	NULL
GrpL	NULL
associates	NULL
with	NULL
SLP-76	NULL
and	NULL
regulates	NULL
NF-AT	NULL
activation	NULL
(	NULL
Figs	NULL
.	NULL

3-6	NULL
)	NULL
,	NULL
one	NULL
testable	NULL
possibility	NULL
is	NULL
that	NULL
a	NULL
trimolecular	NULL
interaction	NULL
among	NULL
SLP-76	NULL
,	NULL
Vav	NULL
,	NULL
and	NULL
GrpL	NULL
may	NULL
be	NULL
required	NULL
for	NULL
optimal	NULL
NF-	NULL
AT	NULL
activation	NULL
and	NULL
reorganization	NULL
of	NULL
cytoskeleton	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

During	NULL
the	NULL
course	NULL
of	NULL
this	NULL
study	NULL
,	NULL
two	NULL
other	NULL
groups	NULL
independently	NULL
identified	NULL
the	NULL
same	NULL
gene	NULL
and	NULL
protein	NULL
as	NULL
we	NULL
describe	NULL
herein	NULL
,	NULL
which	NULL
they	NULL
have	NULL
designated	NULL
as	NULL
Mona	NULL
(	NULL
34	NULL
)	NULL
and	NULL
Gads	NULL
(	NULL
55	NULL
,	NULL
56	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
data	NULL
suggest	NULL
that	NULL
in	NULL
nonlym-phoid	NULL
cells	NULL
,	NULL
GrpL	NULL
(	NULL
Mona/	NULL
Gads	NULL
)	NULL
may	NULL
interact	NULL
with	NULL
either	NULL
the	NULL
M-CSF	NULL
receptor	NULL
,	NULL
c-fms	NULL
(	NULL
54	NULL
)	NULL
,	NULL
or	NULL
with	NULL
c-kit	NULL
(	NULL
55	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
our	NULL
results	NULL
,	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

(	NULL
56	NULL
)	NULL
independently	NULL
found	NULL
that	NULL
GrpL	NULL
can	NULL
bind	NULL
to	NULL
SLP-76	NULL
and	NULL
together	NULL
with	NULL
SLP-76	NULL
can	NULL
promote	NULL
the	NULL
activation	NULL
of	NULL
NF-AT	NULL
in	NULL
T	NULL
cells	NULL
We	NULL
have	NULL
recently	NULL
identified	NULL
another	NULL
adaptor	NULL
protein	NULL
,	NULL
BAM-32	NULL
,	NULL
which	NULL
unlike	NULL
GrpL	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
and	NULL
reference	NULL
56	NULL
)	NULL
,	NULL
SLP-76	NULL
(	NULL
18-21	NULL
)	NULL
,	NULL
or	NULL
the	NULL
B	NULL
cell	NULL
adaptor	NULL
BLNK	NULL
(	NULL
57	NULL
)	NULL
,	NULL
inhibits	NULL
the	NULL
activation	NULL
NFAT	NULL
(	NULL
Marshall	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
H.	NULL
Niiro	NULL
,	NULL
T.J.	NULL
Yun	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

Clark	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
antigen	NULL
receptor-induced	NULL
activation	NULL
of	NULL
NF-AT	NULL
in	NULL
lymphocytes	NULL
is	NULL
carefully	NULL
regulated	NULL
by	NULL
adaptor	NULL
proteins	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Gary	NULL
Koretzky	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
the	NULL
pEF	NULL
,	NULL
pEF-SLP-76	NULL
,	NULL
and	NULL
NF-AT	NULL
Luc	NULL
expression	NULL
vectors	NULL
and	NULL
the	NULL
C305	NULL
anti-TCR	NULL
mAb	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
G.	NULL
Lynn	NULL
Law	NULL
for	NULL
access	NULL
to	NULL
the	NULL
luminometer	NULL
,	NULL
and	NULL
Drs	NULL
.	NULL

Nancy	NULL
Boerth	NULL
,	NULL
Jennifer	NULL
Westendorf	NULL
,	NULL
and	NULL
Michelle	NULL
Tallquist	NULL
for	NULL
suggestions	NULL
on	NULL
reporter	NULL
gene	NULL
assays	NULL
.	NULL

1251	NULL
Law	NULL
et	NULL
al	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
GM42508	NULL
,	NULL
GM37905	NULL
,	NULL
and	NULL
DEOO859	NULL
,	NULL
and	NULL
by	NULL
fellowships	NULL
from	NULL
the	NULL
Cancer	NULL
Research	NULL
Fund	NULL
of	NULL
the	NULL
Damon	NULL
R	NULL
unyon-	NULL
Walter	NULL
Winchell	NULL
Foundation	NULL
(	NULL
P.M.	NULL
Chaudhary	NULL
)	NULL
and	NULL
the	NULL
Medical	NULL
R	NULL
esearch	NULL
Council	NULL
of	NULL
Canada	NULL
(	NULL
A.J	NULL
.	NULL

Marshall	NULL
)	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Edward	NULL
A.	NULL
Clark	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Box	NULL
357242	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98195	NULL
.	NULL

Phone	NULL
:	NULL
206-543-8706	NULL
;	NULL
Fax	NULL
:	NULL
206-685-0305	NULL
;	NULL
E-mail	NULL
:	NULL
eclark	NULL
@	NULL
bart.rprc	NULL
.	NULL

washington.edu	NULL
C.-L.	NULL
Law	NULL
's	NULL
present	NULL
address	NULL
is	NULL
Xeyte	NULL
Therapies	NULL
Inc.	NULL
,	NULL
2203	NULL
Airport	NULL
Way	NULL
South	NULL
,	NULL
Suite	NULL
300	NULL
,	NULL
Seattle	NULL
,	NULL
W	NULL
A	NULL
98134	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
27	NULL
Odober	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
18	NULL
February	NULL
1999	NULL
.	NULL

References	NULL
1	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

Park	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
H.W	NULL
.	NULL

R	NULL
ho	NULL
,	NULL
and	NULL
S	NULL
$	NULL
.G	NULL
.	NULL

Rhee	NULL
.	NULL

1991	NULL
.	NULL

CD3	NULL
stimulation	NULL
causes	NULL
phosphorylation	NULL
of	NULL
phospholipase	NULL
C-gamma	NULL
1	NULL
on	NULL
serine	NULL
and	NULL
tyrosine	NULL
residues	NULL
in	NULL
a	NULL
human	NULL
T-cell	NULL
line	NULL
.	NULL

Pre	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

88:5453-5456.	NULL
.	NULL

Secrist	NULL
,	NULL
J.P.	NULL
,	NULL
L.	NULL
Karnitz	NULL
,	NULL
and	NULL
R	NULL
.T	NULL
.	NULL

Abraham	NULL
.	NULL

1991	NULL
.	NULL

T-cell	NULL
an	NULL
tigen	NULL
receptor	NULL
ligation	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
phospholipase	NULL
C-gamma	NULL
1	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

266:12135-12139.	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Koretzky	NULL
,	NULL
R.C	NULL
.	NULL

Schatzman	NULL
,	NULL
and	NULL
T.	NULL
Kadlecek	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
activation	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
phospholipase	NULL
C-gamma	NULL
1	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

88:5484-5488.	NULL
.	NULL

Fukazawa	NULL
,	NULL
T.	NULL
,	NULL
K.A	NULL
.	NULL

Reedquist	NULL
,	NULL
G.	NULL
Panchamoorthy	NULL
,	NULL
S.	NULL
Sol	NULL
toff	NULL
,	NULL
T.	NULL
Trub	NULL
,	NULL
B.	NULL
Druker	NULL
,	NULL
L.	NULL
Cantley	NULL
,	NULL
S.E	NULL
.	NULL

Shoelson	NULL
,	NULL
and	NULL
H.	NULL
Band	NULL
.	NULL

1995	NULL
.	NULL

T	NULL
cell	NULL
activation-dependent	NULL
association	NULL
between	NULL
the	NULL
p85	NULL
subunit	NULL
of	NULL
the	NULL
phosphatidylinosito	NULL
!	NULL

l	NULL
3-kinase	NULL
and	NULL
Grb2/	NULL
phospholipase	NULL
C-gamma	NULL
binding	NULL
phosphotyrosyl	NULL
protein	NULL
pp36/	NULL
38	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:20177-20182.	NULL
.	NULL

Motto	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
SE	NULL
.	NULL

Ross	NULL
,	NULL
JK	NULL
.	NULL

Jackman	NULL
,	NULL
Q	NULL
.	NULL

Sun	NULL
,	NULL
AL	NULL
.	NULL

Olson	NULL
,	NULL
P.R	NULL
.	NULL

Findell	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1994	NULL
.	NULL

In	NULL
vivo	NULL
association	NULL
of	NULL
Grb2	NULL
with	NULL
pp116	NULL
,	NULL
a	NULL
substrate	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor-acti-vated	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

269:21608-21613.	NULL
.	NULL

Jackman	NULL
,	NULL
JK	NULL
.	NULL

,	NULL
D.G	NULL
.	NULL

Motto	NULL
,	NULL
Q	NULL
.	NULL

Sun	NULL
,	NULL
M.	NULL
Tanemoto	NULL
,	NULL
C.W	NULL
.	NULL

Turck	NULL
,	NULL
G.A	NULL
.	NULL

Peltz	NULL
,	NULL
G.A	NULL
.	NULL

Koretzky	NULL
,	NULL
and	NULL
P.R	NULL
.	NULL

Findell	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
SLP-76	NULL
,	NULL
a	NULL
76-kDa	NULL
tyrosine	NULL
phosphoprotein	NULL
associated	NULL
with	NULL
Grb2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

270	NULL
:	NULL
7029-7032.	NULL
.	NULL

Fukazawa	NULL
,	NULL
T.	NULL
,	NULL
K.A	NULL
.	NULL

Reedquist	NULL
,	NULL
T.	NULL
Trub	NULL
,	NULL
S.	NULL
Soltoff	NULL
,	NULL
G.	NULL
Pan	NULL
chamoorthy	NULL
,	NULL
B.	NULL
Druker	NULL
,	NULL
L.	NULL
Cantley	NULL
,	NULL
S.E	NULL
.	NULL

Shoelson	NULL
,	NULL
and	NULL
H.	NULL
Band	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
SH3	NULL
domain-binding	NULL
T	NULL
cell	NULL
tyrosyl	NULL
phosphoprotein	NULL
p120	NULL
.	NULL

Demonstration	NULL
of	NULL
its	NULL
identity	NULL
with	NULL
the	NULL
c-cbl	NULL
protooncogene	NULL
product	NULL
and	NULL
in	NULL
vivo	NULL
complexes	NULL
with	NULL
Fyn	NULL
,	NULL
Grb2	NULL
,	NULL
and	NULL
phosphatidylinositol	NULL
3-kinase	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

270:19141-19150.	NULL
.	NULL

Margolis	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
Hu	NULL
,	NULL
S.	NULL
Katzav	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
JM	NULL
.	NULL

Oliver	NULL
,	NULL
A.	NULL
UIl-	NULL
rich	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1992	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
vay	NULL
proto-oncogene	NULL
product	NULL
containing	NULL
SH2	NULL
domain	NULL
and	NULL
transcription	NULL
factor	NULL
motifs	NULL
.	NULL

Natwre	NULL
.	NULL

356:71-74.	NULL
.	NULL

Tuosto	NULL
,	NULL
L.	NULL
,	NULL
F.	NULL
Michel	NULL
,	NULL
and	NULL
O.	NULL
Acuto	NULL
.	NULL

1996.	NULL
p95vav	NULL
associates	NULL
with	NULL
tyrosine-phosphorylated	NULL
SLP-76	NULL
in	NULL
antigen-stimulated	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1161-1166	NULL
.	NULL

Gilliland	NULL
,	NULL
LK	NULL
.	NULL

,	NULL
G.L	NULL
.	NULL

Schieven	NULL
,	NULL
N.A	NULL
.	NULL

Norris	NULL
,	NULL
S.B	NULL
.	NULL

Kanner	NULL
,	NULL
A.	NULL
Aruffo	NULL
,	NULL
and	NULL
J.A	NULL
.	NULL

Ledbetter	NULL
.	NULL

1992	NULL
.	NULL

Lymphocyte	NULL
lineage-restricted	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
that	NULL
bind	NULL
PLC	NULL
gamma	NULL
1	NULL
SH2	NULL
domains	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

267:13610-13616	NULL
.	NULL

Buday	NULL
,	NULL
L.	NULL
,	NULL
SE	NULL
.	NULL

Egan	NULL
,	NULL
V.-P.	NULL
Rodriguez	NULL
,	NULL
D.A	NULL
.	NULL

Cantrell	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Downward	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
complex	NULL
of	NULL
Grb2	NULL
adaptor	NULL
protein	NULL
,	NULL
Sos	NULL
exchange	NULL
factor	NULL
,	NULL
and	NULL
a	NULL
36-kDa	NULL
membrane-bound	NULL
tyrosine	NULL
1252	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23.	NULL
phosphoprotein	NULL
is	NULL
implicated	NULL
in	NULL
ras	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:9019-9023	NULL
.	NULL

Sich	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Batzer	NULL
,	NULL
J.	NULL
Schlessinger	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
1994	NULL
.	NULL

GR	NULL
B2	NULL
and	NULL
phospholipase	NULL
C-gamma	NULL
1	NULL
associate	NULL
with	NULL
a	NULL
36-	NULL
to	NULL
38-kilodalton	NULL
phosphotyrosine	NULL
protein	NULL
after	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4435-4442	NULL
.	NULL

Zhang	NULL
,	NULL
W.	NULL
,	NULL
L.-J	NULL
.	NULL

Sloan	NULL
,	NULL
J	NULL
.	NULL

Kitchen	NULL
,	NULL
RP	NULL
.	NULL

Trible	NULL
,	NULL
and	NULL
LE	NULL
.	NULL

Samelson	NULL
.	NULL

1998	NULL
.	NULL

LAT	NULL
:	NULL
the	NULL
ZAP-70	NULL
tyrosine	NULL
kinase	NULL
substrate	NULL
that	NULL
links	NULL
T	NULL
cell	NULL
receptor	NULL
to	NULL
cellular	NULL
activation	NULL
.	NULL

Cell	NULL
.	NULL

92:83-92	NULL
.	NULL

Weber	NULL
,	NULL
JR.	NULL
,	NULL
S.	NULL
Orstavik	NULL
,	NULL
K.M	NULL
.	NULL

Torgersen	NULL
,	NULL
N.C.	NULL
Danbolt	NULL
,	NULL
SF	NULL
.	NULL

Berg	NULL
,	NULL
JC	NULL
.	NULL

Ryan	NULL
,	NULL
K.	NULL
Taskén	NULL
,	NULL
J.B.	NULL
Imboden	NULL
,	NULL
and	NULL
JT	NULL
.	NULL

Vaage	NULL
.	NULL

1998	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
pp36	NULL
,	NULL
a	NULL
tyrosine-phosphorylated	NULL
adaptor	NULL
protein	NULL
selectively	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
187	NULL
:	NULL
1157-1161	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.R	NULL
.	NULL

Littman	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
.	NULL

Cell	NULL
.	NULL

76:263-274	NULL
.	NULL

Chan	NULL
,	NULL
A.C.	NULL
,	NULL
and	NULL
A.S.	NULL
Shaw	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
by	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Cur	NULL
:	NULL
Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8:394-401	NULL
.	NULL

Wange	NULL
,	NULL
RL	NULL
.	NULL

,	NULL
and	NULL
LE	NULL
.	NULL

Samelson	NULL
.	NULL

1996	NULL
.	NULL

Complex	NULL
com-plexes	NULL
:	NULL
signaling	NULL
at	NULL
the	NULL
TCR	NULL
.	NULL

Immunity	NULL
.	NULL

5:197-205	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
,	NULL
D.G	NULL
.	NULL

Motto	NULL
,	NULL
G.A	NULL
.	NULL

Koretzky	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
1996	NULL
.	NULL

Vav	NULL
and	NULL
SLP-76	NULL
interact	NULL
and	NULL
functionally	NULL
cooperate	NULL
in	NULL
IL-2	NULL
gene	NULL
activation	NULL
.	NULL

Immunity	NULL
.	NULL

4:593-602	NULL
.	NULL

Raab	NULL
,	NULL
M.	NULL
,	NULL
A.J	NULL
.	NULL

da	NULL
Silva	NULL
,	NULL
P.R	NULL
.	NULL

Findell	NULL
,	NULL
and	NULL
C.E	NULL
.	NULL

Rudd	NULL
.	NULL

1997	NULL
.	NULL

R	NULL
egulation	NULL
of	NULL
Vav-SLP-76	NULL
binding	NULL
by	NULL
ZAP-70	NULL
and	NULL
its	NULL
relevance	NULL
to	NULL
TCR	NULL
zeta/	NULL
CD3	NULL
induction	NULL
of	NULL
interleukin-2	NULL
.	NULL

Immunity	NULL
.	NULL

6:155-164	NULL
.	NULL

Fang	NULL
,	NULL
N.	NULL
,	NULL
D.G	NULL
.	NULL

Motto	NULL
,	NULL
SE	NULL
.	NULL

Ross	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1996	NULL
.	NULL

Tyrosines	NULL
113	NULL
,	NULL
128	NULL
,	NULL
and	NULL
145	NULL
of	NULL
SLP-76	NULL
are	NULL
required	NULL
for	NULL
optimal	NULL
augmentation	NULL
of	NULL
NFAT	NULL
promoter	NULL
activity	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

157:3769-3773	NULL
.	NULL

Motto	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
SE	NULL
.	NULL

Ross	NULL
,	NULL
J.	NULL
Wu	NULL
,	NULL
T.-LR	NULL
.	NULL

Hendricks	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1996	NULL
.	NULL

Implication	NULL
of	NULL
the	NULL
GR	NULL
B2-associated	NULL
phosphoprotein	NULL
SLP-76	NULL
in	NULL
T	NULL
cell	NULL
receptor-mediated	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
183:1937-1943	NULL
.	NULL

Clements	NULL
,	NULL
JL	NULL
.	NULL

,	NULL
B.	NULL
Yang	NULL
,	NULL
S.E	NULL
.	NULL

Ross-	NULL
Barta	NULL
,	NULL
S.L	NULL
.	NULL

Eliason	NULL
,	NULL
R.F	NULL
.	NULL

Hrstka	NULL
,	NULL
R.A.	NULL
Williamson	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1998	NULL
.	NULL

Requirement	NULL
for	NULL
the	NULL
leukocyte-	NULL
specific	NULL
adapter	NULL
SLP-76	NULL
for	NULL
normal	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Sdere	NULL
.	NULL

281:416-419	NULL
.	NULL

Pivniouk	NULL
,	NULL
V.	NULL
,	NULL
E.	NULL
Tsitsikov	NULL
,	NULL
P.	NULL
Swinton	NULL
,	NULL
G.	NULL
Rathbun	NULL
,	NULL
FW	NULL
.	NULL

Alt	NULL
,	NULL
and	NULL
R.S	NULL
.	NULL

Geha	NULL
.	NULL

1998	NULL
.	NULL

Impaired	NULL
viability	NULL
and	NULL
profound	NULL
block	NULL
in	NULL
thymocyte	NULL
development	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
adaptor	NULL
protein	NULL
SLP-76	NULL
.	NULL

Cell	NULL
.	NULL

94:229-238.	NULL
.	NULL

Koretzky	NULL
,	NULL
G.A	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Grb2-associated	NULL
proteins	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

18:401-406	NULL
.	NULL

Novel	NULL
Adaptor	NULL
Molecule	NULL
That	NULL
Regulates	NULL
NF-AT	NULL
Activation	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Osman	NULL
,	NULL
N.	NULL
,	NULL
S.C.	NULL
Lucas	NULL
,	NULL
H.	NULL
Turner	NULL
,	NULL
and	NULL
D.	NULL
Cantrell	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
Shc	NULL
and	NULL
the	NULL
tyrosine	NULL
kinase	NULL
ZAP-70	NULL
with	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
zeta	NULL
chain	NULL
tyrosine-based	NULL
activation	NULL
motif	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

270:13981-13986	NULL
.	NULL

Vojtek	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
and	NULL
J.C.	NULL
Der	NULL
.	NULL

1998	NULL
.	NULL

Increasing	NULL
complexity	NULL
of	NULL
the	NULL
R	NULL
as	NULL
signaling	NULL
pathway	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

273:19925-19928	NULL
.	NULL

Reif	NULL
,	NULL
K.	NULL
,	NULL
L.	NULL
Buday	NULL
,	NULL
J	NULL
.	NULL

Downward	NULL
,	NULL
and	NULL
D.A	NULL
.	NULL

Cantrell	NULL
.	NULL

1994	NULL
.	NULL

SH3	NULL
domains	NULL
of	NULL
the	NULL
adapter	NULL
molecule	NULL
Grb2	NULL
complex	NULL
with	NULL
two	NULL
proteins	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
the	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
protein	NULL
Sos	NULL
and	NULL
a	NULL
75-kDa	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
T	NULL
cell	NULL
antigen	NULL
receptor-activated	NULL
tyrosine	NULL
kinases	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

269:14081-14087	NULL
.	NULL

Meisner	NULL
,	NULL
H.	NULL
,	NULL
BR	NULL
.	NULL

Conway	NULL
,	NULL
D.	NULL
Hartley	NULL
,	NULL
and	NULL
M.P	NULL
.	NULL

Czech	NULL
.	NULL

1995	NULL
.	NULL

Interactions	NULL
of	NULL
Cbl	NULL
with	NULL
Grb2	NULL
and	NULL
phosphatidylinositol	NULL
3'-kinase	NULL
in	NULL
activated	NULL
Jurkat	NULL
cells	NULL
Mol	NULL
.	NULL

Coll	NULL
.	NULL

Biol	NULL
.	NULL

15:3571-3578	NULL
.	NULL

Donovan	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Y.	NULL
Ota	NULL
,	NULL
W.Y	NULL
.	NULL

Langdon	NULL
,	NULL
and	NULL
LE	NULL
.	NULL

Samelson	NULL
.	NULL

1996	NULL
.	NULL

R	NULL
egulation	NULL
of	NULL
the	NULL
association	NULL
of	NULL
p120cbl	NULL
with	NULL
Grb2	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

X	NULL
Biol	NULL
Chem	NULL
.	NULL

271:26369-26374	NULL
.	NULL

Wardenburg	NULL
,	NULL
J.B.	NULL
,	NULL
C.	NULL
Fu	NULL
,	NULL
JK	NULL
.	NULL

Jackman	NULL
,	NULL
H.	NULL
Flotow	NULL
,	NULL
S.E	NULL
.	NULL

Wilkinson	NULL
,	NULL
D.H.	NULL
Williams	NULL
,	NULL
R.	NULL
Johnson	NULL
,	NULL
G.	NULL
Kong	NULL
,	NULL
A.C.	NULL
Chan	NULL
,	NULL
and	NULL
P.R	NULL
.	NULL

Findell	NULL
.	NULL

1996	NULL
.	NULL

Phosphorylation	NULL
of	NULL
SLP-76	NULL
by	NULL
the	NULL
ZAP-70	NULL
protein-tyrosine	NULL
kinase	NULL
is	NULL
required	NULL
for	NULL
T-cell	NULL
receptor	NULL
function	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

271:19641-19644	NULL
.	NULL

Buday	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Khwaja	NULL
,	NULL
S.	NULL
Sipeki	NULL
,	NULL
A.	NULL
Farago	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Downward	NULL
.	NULL

1996	NULL
.	NULL

Interactions	NULL
of	NULL
Cbl	NULL
with	NULL
two	NULL
adapter	NULL
proteins	NULL
,	NULL
Grb2	NULL
and	NULL
Crk	NULL
,	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

271:6159-6163	NULL
.	NULL

Reedquist	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
T.	NULL
Fukazawa	NULL
,	NULL
G.	NULL
Panchamoorthy	NULL
,	NULL
W.Y	NULL
.	NULL

Langdon	NULL
,	NULL
S.E	NULL
.	NULL

Shoelson	NULL
,	NULL
B.J	NULL
.	NULL

Druker	NULL
,	NULL
and	NULL
H.	NULL
Band	NULL
.	NULL

1996	NULL
.	NULL

Stimulation	NULL
through	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
induces	NULL
Cbl	NULL
association	NULL
with	NULL
Crk	NULL
proteins	NULL
and	NULL
the	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
protein	NULL
C3G	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:8435-8442	NULL
.	NULL

Feng	NULL
,	NULL
G.S	NULL
.	NULL

,	NULL
Y.B	NULL
.	NULL

Ouyang	NULL
,	NULL
D.P	NULL
.	NULL

Hu	NULL
,	NULL
Z.Q	NULL
.	NULL

Shi	NULL
,	NULL
R.	NULL
Gentz	NULL
,	NULL
and	NULL
J.	NULL
Ni	NULL
.	NULL

1996	NULL
.	NULL

Grap	NULL
is	NULL
a	NULL
novel	NULL
SH3-SH2-SH3	NULL
adaptor	NULL
protein	NULL
that	NULL
couples	NULL
tyrosine	NULL
kinases	NULL
to	NULL
the	NULL
Ras	NULL
pathway	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

271:12129-12132	NULL
.	NULL

Trub	NULL
,	NULL
T.	NULL
,	NULL
J.D	NULL
.	NULL

Frantz	NULL
,	NULL
M.	NULL
Miyazaki	NULL
,	NULL
H.	NULL
Band	NULL
,	NULL
and	NULL
SE	NULL
.	NULL

Shoelson	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
role	NULL
of	NULL
a	NULL
lymphoid-restricted	NULL
,	NULL
Grb2-like	NULL
SH3-SH2-SH3	NULL
protein	NULL
in	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

272:894-902	NULL
.	NULL

Leprince	NULL
,	NULL
C.	NULL
,	NULL
KE	NULL
.	NULL

Draves	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
R.M	NULL
.	NULL

Torres	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

Clark	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
molecular	NULL
components	NULL
associated	NULL
with	NULL
surface	NULL
immunoglobulin	NULL
M	NULL
in	NULL
human	NULL
B	NULL
lym-phocytes	NULL
:	NULL
presence	NULL
of	NULL
tyrosine	NULL
and	NULL
serine/threonine	NULL
protein	NULL
kinases	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:2093-2099	NULL
.	NULL

Mayer	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
and	NULL
M.J.	NULL
Eck	NULL
.	NULL

1995	NULL
.	NULL

SH3	NULL
domains	NULL
.	NULL

Minding	NULL
your	NULL
p	NULL
's	NULL
and	NULL
q	NULL
's	NULL
.	NULL

Cur	NULL
:	NULL
Biol	NULL
.	NULL

5:364-367	NULL
.	NULL

Kuriyan	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Cowburn	NULL
.	NULL

1997	NULL
.	NULL

Modular	NULL
peptide	NULL
recognition	NULL
domains	NULL
in	NULL
eukaryotic	NULL
signaling	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biophys	NULL
.	NULL

Biomol	NULL
.	NULL

Stud	NULL
.	NULL

26:259-298	NULL
.	NULL

Lowenstein	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
R	NULL
.J	NULL
.	NULL

Daly	NULL
,	NULL
A.G.	NULL
Batzer	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
B.	NULL
Margolis	NULL
,	NULL
R.	NULL
Lammers	NULL
,	NULL
A.	NULL
Ullrich	NULL
,	NULL
EY	NULL
.	NULL

Skolnik	NULL
,	NULL
S.-D.	NULL
Bar	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
SH2	NULL
and	NULL
SH3	NULL
domain-containing	NULL
protein	NULL
GR	NULL
B2	NULL
links	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
to	NULL
ras	NULL
signaling	NULL
.	NULL

Cell	NULL
.	NULL

70:431-442	NULL
.	NULL

Musci	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
D.G	NULL
.	NULL

Motto	NULL
,	NULL
SE	NULL
.	NULL

Ross	NULL
,	NULL
N.	NULL
Fang	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1997	NULL
.	NULL

Three	NULL
domains	NULL
of	NULL
SLP-76	NULL
are	NULL
required	NULL
for	NULL
its	NULL
optimal	NULL
function	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

159:1639-1647.	NULL
da	NULL
Silva	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Z.	NULL
Li	NULL
,	NULL
C.	NULL
de	NULL
Vera	NULL
,	NULL
E.	NULL
Canto	NULL
,	NULL
P.	NULL
Findell	NULL
,	NULL
and	NULL
C.E	NULL
.	NULL

Rudd	NULL
.	NULL

1997	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
novel	NULL
T-cell	NULL
protein	NULL
FYB	NULL
that	NULL
binds	NULL
FYN	NULL
and	NULL
SH2-domain-containing	NULL
leukocyte	NULL
protein	NULL
76	NULL
and	NULL
modulates	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

Proc	NULL
Nal	NULL
Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

94:7493-1498	NULL
.	NULL

Musci	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
T.-LR	NULL
.	NULL

Hendricks	NULL
,	NULL
D.G	NULL
.	NULL

Motto	NULL
,	NULL
M.	NULL
Paskind	NULL
,	NULL
J.	NULL
Kamens	NULL
,	NULL
C.W	NULL
.	NULL

Turck	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1997	NULL
.	NULL

Molecu-	NULL
1253	NULL
Law	NULL
et	NULL
al	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57.	NULL
lar	NULL
cloning	NULL
of	NULL
SLAP-130	NULL
,	NULL
an	NULL
SLP-76-associated	NULL
substrate	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor-stimulated	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:11674-11677	NULL
.	NULL

Fra	NULL
,	NULL
A.M.	NULL
,	NULL
E.	NULL
Williamson	NULL
,	NULL
K.	NULL
Simons	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Parton	NULL
.	NULL

1995	NULL
.	NULL

De	NULL
novo	NULL
formation	NULL
of	NULL
caveolae	NULL
in	NULL
lymphocytes	NULL
by	NULL
expression	NULL
of	NULL
VIP21-caveolin	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sd	NULL
.	NULL

USA	NULL
.	NULL

92	NULL
;	NULL
8655-8659	NULL
.	NULL

Brown	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
and	NULL
E.	NULL
London	NULL
.	NULL

1997	NULL
.	NULL

Structure	NULL
of	NULL
detergent-resistant	NULL
membrane	NULL
domains	NULL
:	NULL
does	NULL
phase	NULL
separation	NULL
occur	NULL
in	NULL
biological	NULL
membranes	NULL
?	NULL

Biodean	NULL
.	NULL

Bigphys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

240:1-7.	NULL
.	NULL

Simons	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
E.	NULL
Ikonen	NULL
.	NULL

1997	NULL
.	NULL

Functional	NULL
rafts	NULL
in	NULL
cell	NULL
membranes	NULL
.	NULL

Nature	NULL
.	NULL

387:569-572	NULL
.	NULL

Zhang	NULL
,	NULL
W.	NULL
,	NULL
R.P	NULL
.	NULL

Trible	NULL
,	NULL
and	NULL
LE	NULL
.	NULL

Samelson	NULL
.	NULL

1998	NULL
.	NULL

LAT	NULL
palmitoylation	NULL
:	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
membrane	NULL
microdomain	NULL
targeting	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Immunity	NULL
.	NULL

9:239-246	NULL
.	NULL

Xavier	NULL
,	NULL
R.	NULL
,	NULL
T.	NULL
Brennan	NULL
,	NULL
Q.	NULL
Li	NULL
,	NULL
C.	NULL
McCormack	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1998	NULL
.	NULL

Membrane	NULL
compartmentation	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Immunity	NULL
.	NULL

8:723-732	NULL
.	NULL

Xiao	NULL
,	NULL
S.	NULL
,	NULL
D.W.	NULL
Rose	NULL
,	NULL
T.	NULL
Sasaoka	NULL
,	NULL
H.	NULL
Maegawa	NULL
,	NULL
TR	NULL
.	NULL

Burke	NULL
,	NULL
J.	NULL
,	NULL
P.P	NULL
.	NULL

Roller	NULL
,	NULL
SE	NULL
.	NULL

Shoelson	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Oleféky	NULL
.	NULL

1994	NULL
.	NULL

Syp	NULL
(	NULL
SH-PTP	NULL
?	NULL
)	NULL

is	NULL
a	NULL
positive	NULL
mediator	NULL
of	NULL
growth	NULL
factor-stimulated	NULL
mitogenic	NULL
signal	NULL
transduction	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

269:21244-21248	NULL
.	NULL

Zhao	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Tan	NULL
,	NULL
JH	NULL
.	NULL

Wright	NULL
,	NULL
C.D	NULL
.	NULL

Diltz	NULL
,	NULL
S.H	NULL
.	NULL

Shen	NULL
,	NULL
E.G	NULL
.	NULL

Krebs	NULL
,	NULL
and	NULL
EH	NULL
.	NULL

Fischer	NULL
.	NULL

1995	NULL
.	NULL

Altered	NULL
expression	NULL
of	NULL
protein-tyrosine	NULL
phosphatase	NULL
2C	NULL
in	NULL
293	NULL
cells	NULL
affects	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:11765-11769	NULL
.	NULL

Marengere	NULL
,	NULL
LE	NULL
.	NULL

,	NULL
P.	NULL
Waterhouse	NULL
,	NULL
G.S	NULL
.	NULL

Duncan	NULL
,	NULL
H.W	NULL
.	NULL

Mittrucker	NULL
,	NULL
G.S	NULL
.	NULL

Feng	NULL
,	NULL
and	NULL
TW	NULL
.	NULL

Mak	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
by	NULL
tyrosine	NULL
phosphatase	NULL
SYP	NULL
association	NULL
with	NULL
CTLA-4	NULL
.	NULL

Sdene	NULL
.	NULL

272:1170-1173	NULL
.	NULL

Frearson	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
and	NULL
D.R	NULL
.	NULL

Alexander	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
phosphotyrosine	NULL
phosphatase	NULL
SHP-2	NULL
participates	NULL
in	NULL
a	NULL
multimeric	NULL
signaling	NULL
complex	NULL
and	NULL
regulates	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
coupling	NULL
to	NULL
the	NULL
R	NULL
as	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
pathway	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
187:1417-1426	NULL
.	NULL

Crespo	NULL
,	NULL
P.	NULL
,	NULL
KE	NULL
.	NULL

Schuebel	NULL
,	NULL
A.A.	NULL
Ostrom	NULL
,	NULL
J.S	NULL
.	NULL

Gutkind	NULL
,	NULL
and	NULL
X.R	NULL
.	NULL

Bustelo	NULL
.	NULL

1997	NULL
.	NULL

Phosphotyrosine-dependent	NULL
activation	NULL
of	NULL
Rac-1	NULL
GDP/GTP	NULL
exchange	NULL
by	NULL
the	NULL
vav	NULL
proto-oncogene	NULL
product	NULL
.	NULL

Nature	NULL
.	NULL

385:169-172	NULL
.	NULL

Reif	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
D.A	NULL
.	NULL

Cantrell	NULL
.	NULL

1998	NULL
.	NULL

Networking	NULL
R	NULL
ho	NULL
family	NULL
GTPases	NULL
in	NULL
lymphocytes	NULL
.	NULL

Immunity	NULL
.	NULL

8:395-401	NULL
.	NULL

Wardenburg	NULL
,	NULL
J.B.	NULL
,	NULL
R.	NULL
Pappu	NULL
,	NULL
J.-Y	NULL
.	NULL

Bu	NULL
,	NULL
B.	NULL
Mayer	NULL
,	NULL
J.	NULL
Cher-noff	NULL
,	NULL
D.	NULL
Straus	NULL
,	NULL
and	NULL
A.C.	NULL
Chan	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
PAK	NULL
activation	NULL
and	NULL
the	NULL
T	NULL
cell	NULL
cytoskeleton	NULL
by	NULL
the	NULL
linker	NULL
protein	NULL
SLP-76	NULL
.	NULL

Immunity	NULL
.	NULL

9:607-616	NULL
.	NULL

Bourette	NULL
,	NULL
RP	NULL
.	NULL

,	NULL
S.	NULL
Arnaud	NULL
,	NULL
G.	NULL
M.	NULL
Myles	NULL
,	NULL
J.-P.	NULL
Blanchet	NULL
,	NULL
LR	NULL
.	NULL

Rohrschneider	NULL
,	NULL
and	NULL
G.	NULL
Mouchiroud	NULL
.	NULL

1998	NULL
.	NULL

Mona	NULL
,	NULL
a	NULL
novel	NULL
hematopoietic-specific	NULL
adaptor	NULL
interacting	NULL
with	NULL
the	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
,	NULL
is	NULL
implicated	NULL
in	NULL
monocyte/	NULL
macrophage	NULL
development	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

17:7273-17281	NULL
.	NULL

Liu	NULL
,	NULL
SK	NULL
.	NULL

,	NULL
and	NULL
C.J	NULL
.	NULL

McGlade	NULL
.	NULL

1998	NULL
.	NULL

Gads	NULL
is	NULL
a	NULL
novel	NULL
SH2	NULL
and	NULL
SH3	NULL
domain-containing	NULL
adaptor	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
tyrosine-phosphorylated	NULL
Shc	NULL
.	NULL

Oncogene	NULL
.	NULL

17:3073-3082	NULL
.	NULL

Liu	NULL
,	NULL
SK	NULL
.	NULL

,	NULL
N.	NULL
Fang	NULL
,	NULL
G.A	NULL
.	NULL

Koretzky	NULL
,	NULL
and	NULL
C.J	NULL
.	NULL

McGlade	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
hematopoietic-specific	NULL
adaptor	NULL
protein	NULL
Gads	NULL
functions	NULL
in	NULL
T-cell	NULL
signaling	NULL
via	NULL
interactions	NULL
with	NULL
the	NULL
SLP-76	NULL
and	NULL
LAT	NULL
adaptors	NULL
.	NULL

Cur	NULL
:	NULL
Biol	NULL
.	NULL

9:67-75	NULL
.	NULL

Fu	NULL
,	NULL
C.	NULL
,	NULL
C.W	NULL
.	NULL

Turck	NULL
,	NULL
T.	NULL
Kurosaki	NULL
,	NULL
and	NULL
A.C.	NULL
Chan	NULL
.	NULL

1998	NULL
.	NULL

BLNK	NULL
:	NULL
a	NULL
central	NULL
linker	NULL
protein	NULL
in	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

Immunity	NULL
.	NULL

9:93-103	NULL
.	NULL

